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Breast cancer has a strong tendency to develop bone metastases, which effectively 
reduce mobility and survival rate of patients. Osteolytic bone metastasis, which is the 
more destructive form of metastasis, presents characteristics of enhanced osteoclast-
mediated bone resorption and impaired bone formation.  Clinically, sclerotic (tissue 
hardening) development in osteolytic lesions is common but little is known regarding the 
underlying mechanism and intrinsic mechanical property changes.  It was also observed 
that there was a lack of compensatory bone formation in osteolytic bone metastases. The 
effect of tumour cells on bone cell mechanosensing and therefore tissue level adaptation 
remains unknown. Investigating the changes in bone cell mechanical and 
mechanosensing properties could illuminate some of the possible pathological changes in 
bone cells in osteolytic metastasis. 
 In this thesis, a modified method of immunocompetent model of osteolytic 
metastases was established. A novel characterization of sclerotic bone responses using 
densitometric, microstructural and viscoelastic parameters was carried out.  Sclerotic 
response was shown to constitute reactive bone formation accompanied by absence of 
tumor cells. Densitometric and microstructural changes showed increased bone formation 
and enhanced microarchitecture in the trabecular region. Significantly reduced creep 
effect was observed in both trabeculae and cortical bone, whereas nanolevel elastic 
properties did not show a significant difference, despite the active modeling. Thus, it was 
concluded that viscoelastic nanomechanical property would serve as a more sensitive 
indicator of modeling in bone than elastic properties.   
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Through the use of a tumor explants (T) culture, a stronger sustained inhibition of 
bone cells viability, differentiation and mineralization was demonstrated. Tumor explants 
cells were revealed to have metastatic potential and similar phenotypic signature as the 
original cell line, but with higher levels of TGF-β1 released. Here, significant decrease in 
cell stiffness and increase in hysteresis for T-conditioned bone cells were first shown. It 
was positively associated with cytoskeletal changes and possibly with inhibited bone cell 
differentiation. Defective bone matrix deposition was also observed in T-conditioned 
bone cells, which could further affect bone cell attachment and mechanosensing. 
Mechanosensitivity to low magnitude, high frequency (LMHF) vibration was 
demonstrated to be significantly decreased in T-condtioned bone cells and not improved 
with subsequent vibration. By inhibiting PI3K pathway through which TGF-β mediate its 
effect, the inhibition on mechanosensing properties of tumor conditioned bone cells was 
alleviated, possibly through the maintainence of cytoskeletal organization.  Thus, growth 
factors like TGF-β1 could be good pharmocological targets for osteoblast treatment in 
osteolytic metastasis.  
In conclusion, sclerotic development in this immunocompetent model was shown 
to be reactive bone formation with reduced local creep properties. Nano-level viscoelastic 
property was shown to be a sensitive indicator of modelling changes in bone.  In addition, 
the tumor cells inhibition of bone cells viability, functionality, mechanical property and 
mechanosensitivity could contribute to the defunct bone formation activity. It therefore 
reinforces the need to expand on osteoblast-targeted therapy for comprehensive treatment 
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1.1   Project Significance 
In 2009, there were 192, 370 diagnosed cases of invasive breast cancer in 
United States and it is considered the second deadliest type of cancer after lung 
and bronchi cancers (Bussard & Mastro 2009).  Breast cancer has a strong 
tendency to develop bone metastases, where metastasis is defined as the migration 
of cancer cells from primary neoplasm to secondary sites. Bone is one of most 
preferred sites for metastasis, with 60-70% prevalence for patients with advanced 
stages of breast cancer (Clines & Guise 2008).  
  Bone metastases, which lead to bone pain and fracture, nerve 
compression as well as hypercalcemia (with extensive bone lesions), effectively 
reduce the mobility and life expectancy of patients. For instance, breast cancer 
patients with bone metastases have a median survival span of 2 years and 60% 
will suffer from bone fractures (Kozlow & Guise 2005). 
Most cancers tend to fall within a spectrum between two forms of 
metastases i.e. osteoblastic and osteolytic metastases.  Of the two, osteolytic 
metastasis represents a more common and more destructive form of metastasis, 
where there is enhanced bone resorption but bone formation is seemingly 
impaired.  In the case of osteoblastic metastasis, there is increased bone formation 
without previous bone resorption (Kozlow & Guise 2005).  In the both forms of 
bone metastasis, the normal tight coupling of bone resorption (mediated by 
osteoclast) and bone formation processes (mediated by osteoblast) in bone 




Pathological development of osteolytic metastases with breast cancer has 
been associated with the enhanced activation of osteoclasts promoted by 
osteoblasts, which have been affected by tumour cells. Increased levels of 
parathyroid hormone-related protein (PTHrP) released by tumour cells increased 
receptor activator of nuclear factor-κB ligand (RANKL) expression and reduced 
expression of osteoprotegrin (OPG), a RANKL inhibitory protein by osteoblasts 
( Fig. 1). Enhanced levels of RANKL protein, together with reduced levels of 
RANKL inhibitor, activated osteoclast precursors, thus increasing bone resorption 
activity.   
 
 







Transforming growth factor-β (TGFβ), which is subsequently released 
from the bone matrix due to resorption, provided further feedback for tumour 
cells to produce more PTHrP, giving rise to a vicious cycle of destruction 
(Kakonen & Mundy 2003, Kozlow & Guise 2005, Clines & Guise 2008).  
Breast 
cancer cell 
Figure 1: Osteolytic metastases development, via RANKL mediated 
osteoclastogenesis (Kakonen & Mundy 2003).  
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For slow growing or benign lytic lesions, sclerosis (tissue hardening) 
development is a frequent occurrence (Priolo & Cerase 1998) . In a study of 274 
patients over 10 years, regression indicators in osteolytic bone metastasis were 
found to be recalcification of lesion (11.6%), foci of sclerosis around the lesion 
(13.5%) which are apparent as low calcified spots and lack of deterioration of 
lesion (10.5%) over a period of at least 12 months (Huber et al 2002).  
Although sclerosis development in bone is seemingly favorable, little is 
known regarding the intrinsic material and mechanical property changes.   It is 
postulated that the immune system might have an important role in sclerotic 
development for slow-growing lesions, which could serve to limit the growth of 
the lesion.  A study of sclerotic development in osteolytic lesions in an 
immunocompetent model of breast cancer metastasis could help in understanding 
some of the underlying mechanisms and in examining bone mechanical property 
changes.   
There is an important need to cover other existing gaps of knowledge in 
the pathophysiology of bone metastasis which will help pave way for new 
therapeutic options. One existing gap in knowledge is the effect of tumour cells 
on bone cell mechanosensing and restorative bone formation process, of which 
little information is known (Mastro et al 2004).  
Histological evidence based on nude rat model induced with human breast 
cancer cells demonstrated that there was a decrease in the ratio of osteoid surface 
to bone surface (97%), which hinted at defunct bone formation activity as a 
contributor towards the decrease in calcified bone volume (Phadke et al 2006). 
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However, less effort has been expanded on osteoblast-targeted therapy for a 
comprehensive treatment (Casimiro et al 2009).  Standard therapeutic options for 
osteolytic bone metastasis mainly comprised of chemotherapeutic drugs and 
bisphosphonates (Coleman et al 2008). Other modes of treatment have included 
radiotherapy or surgery to bone which often occur in patients with bone 
metastasis (Clines & Guise 2008).  
Bisphosphonates (a class of anti-resorptive drug) have been found to be 
able to successfully reduce skeletal related events in bone such as pathological 
fractures and hypercalcemia (Costa & Major 2009). These drugs preferentially 
bind to hydroxyapatite surfaces of bone and inhibit osteoclast resorption as well 
as induce osteoclast apoptosis. Bisphosphonates have a P-C-P structure, with two 
R side chains that provide the basis for their two main functions and potency, as 
shown in Figure 2.  
 
Figure 2: Chemical Structure of bisphosphonates 
Nonetheless, there was a lack of bone healing reported after bisphosphonate 
treatment (Sasaki et al 1995), which suggested a need to look into restoration of bone 
formation.  As such, it would be pertinent to investigate the effects of tumor cells on bone 
cells (osteoblast lineage), which could provide foundation for the development of 
osteoblast-targeted therapy.   
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With the increasingly different combination therapies that could arise, 
there is also the need for improved methods to evaluate possible differential 
responses in bone in order to optimize therapeutic performance. For instance, 
there were synergistic effects of doxorubicin (anticancer drug) with zoledronic 
acid (bisphosphonate) in inhibiting the development of bone metastasis (Ottewell 
et al 2008). In contrast, some chemotherapeutic drugs such as 17AAG were also 
found to have an adverse effect on bone remodeling and therefore treatment 
efficacy in preventing fractures (Coleman et al 2008). Thus, there is a need for 
improved methods to assess varying bone properties under different drug 
therapies.  
As a hierarchical composite material of mineral hydroxyapatite and 
collagen, bone exhibits viscoelastic behavior at different scales.  Viscoelastic 
behavior is defined as behavior that is a combination of elastic (solid) and viscous 
(liquid) properties (Jones 1999). Viscoelastic mechanical properties have been of 
recent interest as a plausible indicator of bone strength changes (Fortis et al 2004, 
Les et al 2004, Yeni et al 2004, Les et al 2005). Other traditional indicators of 
bone strength changes have involved bone density (Kurth et al 2001), micro-
architecture ( Kurth et al 2001, Fritz et al 2007) and  geometry ( Siu et al 2003, 
Jiang et al 2008). Since bone metastasis represents a degradation of bone integrity 
and increased fracture risk, the combination of densitometric, microstructural and 
viscoelastic parameters to assess bone property changes would be of interest in 
this thesis.   
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These highlighted concerns are in line with recommendations from the 
second Cambridge conference for advancing metastatic bone cancer treatment 
(Coleman et al 2008). These recommendations include: (1) oncogenic bone 
metastasis models maintained in immunocompetent model, (2) new tests to 
evaluate treatment responses and (3) restorative bone formation.  
Therefore, in this thesis, a modified immunocompetent model of osteolytic 
bone metastasis was established and a combination of densitometric, 
microstructural and viscoelastic parameters were used to assess osteolytic and in 
particular, sclerotic healing responses in bone. The effects of tumour on bone cells 
mechanical and mechanosensing property in response to vibration were also 
examined.  The subsequent sections would entail prior literature to the work 














1.2   Use of an immunocompetent model of bone metastasis 
Many studies conducted to understand the mechanism of bone metastasis 
and to compare drug treatment effects have adopted the use of xenograft tumour 
in immuno-compromized animals (Neudert et al 2003, Cowey et al 2007,  
Arrington et al 2008, Chanda et al 2008, Ottewell et al 2008). However, it has 
been suggested that the presence of immune system has a major impact on the 
tumor promotion and suppression (Song et al 2008) and there is a significant 
cross-talk between tumour cells, immune cells and host microenvironment 
(Bussard & Mastro 2009). Thus, it has been argued that an immunocompetent 
model of bone metastasis will be more appropriate in simulating disease 
progression (Coleman et al 2008).  
The establishment of a successful immunocompetent model of bone 
metastasis plays a vital role in the overall project, since the results of the study are 
dependent on tumour growth in bone microenvironment and varying bone 
responses. There have been a number of studies (Bassani et al 1990, Kurth et al 
2001, Medhurst et al 2002, Alvarez et al 2003) which used immunocompetent 
models for stimulating osteolytic bone lesions and they could be categorized into 
four types.   
The first method involved injection of malignant ascites into the bone or 
artery.  Ascites is defined to be an accumulation of fluid in the peritoneal cavity 
and malignant cells in ascitic fluid could be used to induce bone metastases 
(Badraoui et al 2009).  For instance, Wistar rats were injected intra-peritoneally 
with Walker 256 (W256) breast carcinosarcoma cells and malignant ascites was 
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extracted and re-injected into other Wistar rats intra-arterially (Jung et al 1984) or 
in an intra-osseous manner (Mao-Ying et al 2006). In another instance, W256/B 
cells (variant cells of W256) were serially passaged intra-peritoneally in Sprague 
Dawley rats before being re-injected into medullary cavity of healthy rats 
(Badraoui et al 2009).  
 The advantage of this method is that it is highly reproducible in 
establishing osteolytic metastases across different studies (Jung et al 1984, 
Krempien et al 2003, Mao-Ying et al 2006, Badraoui et al 2009).  However, 
significant osteolytic destruction of femur and tibia could be found within a short 
period of time i.e. 7 days (Jung et al 1984) that might not depict clinical cases of 
tumor induced osteolysis which tended to grow more slowly (Body 1993).   
The second method involved intra-osseous injection of tumour cells 
directly into the medullary cavity. In one example, W256 cells were injected into 
the medullary cavity of Fischer 344 rats.  On the other hand, Kurth et al directly 
implanted Walker 256 cells in 0.6% agarose gel enriched with medium into the 
medullary cavity of Sprague Dawley rats (Kurth et al 2000, Kurth et al 2001, 
Kurth et al 2007).  There are some limitations to the protocol, which involved the 
direct inoculation of osteolytic W256 rat breast cancer cells into rat bone. It could 
be pointed out that it does not represent the selective process of cancer metastasis 
i.e. detachment, invasion across vascular walls and into circulation, where only 
0.01% of cancer cells survive to induce metastasis (Fidler 2003).   
Nonetheless, there are obvious advantages of tumour localization, which 
could facilitate for longer host survival and ease of monitoring of tumour growth. 
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Moreover, the use of rat mammary carcinosarcoma (W256 cells) provides some 
clinical relevance as they have characteristics similar to human breast cancer: 
poor immunogenicity and high metastatic ability(Badraoui et al 2009) as well as 
differential response to hormonal treatment(Blouin et al 2005). In addition, 
Kurth‟s methodology appeared to be repeatable over the years of 2000- 2001 and 
2007.  
The third method comprised of injecting syngeneic tumour cells into the 
bone i.e. tumour cells were derived from rats of the same species and injected into 
healthy rats. For instance, MRMT-1 cells were injected into bone of Sprague 
Dawley rats.  MRMT-1 are rat mammary gland carcinoma cells that were pre-
developed in immune-impaired rats of the same species, which were fed with 3-
methylcholanthrene (Medhurst et al 2002).  Another example will be that of 
13762 rat mammary carcinoma cells in Fischer rats, where 13762 cells were 
derived from Fischer rats fed with 7, 12 dimethylbenzanthracene (Alvarez et al 
2003). While a syngeneic model of tumor metastasis is preferrable, the tumor 
cells derived in this manner would be spontaneously metastatic (Medhurst et al 
2002 , Alvarez et al 2003), with dissemination to other sites (Alvarez et al 2003). 
As such, there could be lowered host survival and little possibility of sclerosis 
development which only appears in the case of benign and slow growing lesions.  
The fourth type was to induce localized cancer invasion into the bone e.g. 
injection of Walker 256(A) carcinoma cells into the muscle adjacent to tibia and 
allowing for the cancer cells to invade into the bone  (Guaitani et al 1985, Bassani 
et al 1990). However, it was observed that bone errosion occurred closest to the 
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edge of the tumor and was more representative of an external invasion of bone 
than tumor induced osteolysis.  
After due considerations, a rodent model of bone metastasis modified after 
Kurth‟s protocol (Kurth et al 2000, Kurth et al 2001, Kurth et al 2007) was 
adopted and modification of technique is elaborated under Chapter 2.  
 
1.2.1 Examining bone densitometric and micro-structural changes 
Non-invasive densitometric assessments using peripheral quantitative 
computed tomography (pQCT) and dual-energy X-ray absorptiometry (DXA) 
have been used in monitoring osteolytic effects  (Kurth et al 2001, Mann et al 
2008)  and corresponding drug efficacies in the treatment of bone metastasis 
(Kurth et al 2002, Kurth et al 2007).  
pQCT measures the attenuation of the X-ray radiation passing through 
bone at a pixel resolution of 0.1mm. By using a hydroxyapatite standard, pQCT is 
able to provide corresponding volumetric bone mineral content (vBMC) and 
density (vBMD).  It could also provide site specific (cortical or trabecular) and 
geometric information such as cross sectional area (CSA), cortical thickness and 
cross-sectional moment of inertia (CSMI).   
Since osteolytic metastasis gives rise to deterioration in bone integrity 
resulting in increased fracture risk, bone densitometry and geometric parameters 
could provide useful indicators in assessing bone mass and strength changes.  For 
instance, BMD which indicates amount of mineralized bone mass, was found to 
have a wide range of correlations to fracture load (r = 0.387-0.813) ( Ferretti et al 
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1996, Siu et al 2003, Jiang et al 2008) and failure torque (r
2 
= 0.28) (Kurth et al 
2001).  The wide range of correlations implied that BMD is not sufficient to 
reflect bone strength changes and that bone mechanical behavior is also 
influenced by bone organic components and other factors. Bone geometrical 
properties such cortical CSA and CSMI also yielded moderate correlations i.e. r = 
0.64-0.83 ( Jiang et al 2008, Kokoroghiannis et al 2009) and r = 0.42-0.86 (Jamsa 
et al 1998, Siu et al 2003, Jiang et al 2008) respectively, to fracture load.  
 BMD and geometrical indexes from pQCT are not sufficient as the only 
parameters to assess bone integrity and strength changes as a result of bone 
metastasis.  Bone microstructural changes, which cannot be analyzed using pQCT 
because of its limited resolution, is another important parameter associated with 
bone strength and relative fracture fragility (Krempien et al 2003).  
    The technique of micro-computed tomography is capable of providing 
non-destructive, three-dimensional, high-resolution imaging and assessment of 
bone microstructural properties.  It is capable of identifying bone metastasis 71%-
100% of the time (Slavo et al 2009). For instance, it was reported by Fritz et al 
that imaging of osteolysis using micro-CT has allowed for early detection of 
osteolytic lesions before radiological observance (Fritz et al 2007). However, for 
micrometastases which have not produced enough bone changes, there could be 
failures to detect metastases (Chappard et al 2010). Nevertheless, micro-CT could 
provide an improved diagnosis within a short period of time.  
Quantitative microstructural parameters such as bone volume fraction 
(BV/TV), bone surface density (BS/TV), trabecular thickness (Tb.Th), trabecular 
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separation (Tb.Sp), trabecular number (Tb.N) and structure model index (SMI) 
have already been adopted in number of studies to monitoring relative 
microarchitectural changes in disease models such as osteoporosis (OVX) (Jiang 
et al 2000 , Sheng et al 2008, Lespessailles et al 2009) and bone metastasis (Fritz 
et al 2007, Kurth et al 2007,  Halvorson et al 2008, Ottewell et al 2008). SMI 
quantifies the three-dimensional structure of trabecular bone in terms of plates 
and rods.  It is 0 for ideal plate and 3 for rod-like structure, independent of 
dimension (Lespessailles et al 2006).  
 Strong correlations for BV/TV (R
2 
= 0.83-0.877) (Teo et al 2006, Nazarian 
et al 2008) and moderate correlations to ultimate strength of cancellous bone were 
found for Tb.N (R
2 
= 0.67), Tb.Sp (R
2 
= 0.54) and SMI (R
2 
= 0.56) (Teo et al 
2006). Nonetheless, changes in bone mass, geometric and microstructural 
properties assessed by pQCT and micro-CT techniques are still not adequate in 
providing information on tissue property changes that could affect bone integrity 
and strength.  
  
1.2.2  Examining bone viscoelastic changes 
Bone is a heterogeneous two phase composite material comprising of 
mineral hydroxyapatite crystals and organic components (mainly collagen type I). 
Organic component of bone and water content play important roles towards bone 
viscoelastic behavior, in which mechanical property changes over the loading 
duration (Kim et al 2010).  The strain rate dependence of bone is reported to have 
contributed to a fifth of the human femoral bone strength during high-speed 
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loading in vitro (Les et al 2004). Moreover, remodeling which affects degree of 
mineralization was found to affect damping efficiency at low frequency (6 Hz or 
less) in osteoporotic samples (Les et al 2004). Therefore, viscoelastic tissue 
property changes could constitute another possible indicator that could be 
assessed in development of bone metastasis.  
 Bone viscoelastic behavior could be assessed at the nano-level using 
nanoindentation (Agilent G200 nanoindentor) and at the tissue level using 
dynamic mechanical analysis (DMA 8000 dynamic mechanical analyzer).  One of 
the rationales for examining bone viscoelastic behavior at the nano-level is that it 
can reflect local material property changes of bone that undergoes substantial 
bone remodeling (Tai et al 2007). Thus, it could be indicative of local remodeling 
changes occurring in bone metastasis.  
Nanoindentation technique using Berkovich tip provides the following 
advantages: probing surface with spatial resolution less than 1µm (Rho et al 1997), 
provides quantification of intrinsic microstructural bone properties and new 
aspects to inter-specimen biological variation (Isaksson et al 2010a).  
It could be used to study local viscoelasticity changes, by analyzing the 
creep effect of the bone under constant load using rheological models such as 
Burger  (Isaksson et al 2010a , Isaksson et al 2010b) and Voigt model (Kim et al 
2010).  While Burger and Voigt models were shown to be able to provide 
adequate fitting to experimental results of creep in bone (Isaksson et al 2010a , 
Isaksson et al 2010b, Kim et al 2010), there are simplified assumptions involved 
e.g. Voigt model assumes reversible elastic indentation, whereas irreversible 
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plastic deformation was observed in bone with Berkovich tip indentation. A 
visco-elastic-plastic approach that takes into account plastic deformation (Olesiak 
et al 2010) could constitute a more appropriate model examining creep behavior 
in bone. However, in order to establish a trend and better relate to other literature 
derived values of diseased bone (Kim et al 2013, Yang et al 2013), we have 
adopted Voigt model for creep component in this thesis.  
A variety of approaches have also been utilized to assess the nano-level 
elastic properties by using quasi-static (Ishimoto et al 2011), modified (Li et al 
2012b), semi-dynamic (Isaksson et al 2010a, Isaksson et al 2010b) and dynamic 
loading methods (Yang et al 2013, Pathak et al 2011).  
Nanoindentation has been useful in monitoring localized nanomechanical 
property changes in ovariectomized bones with or without drug administration  
(Bala et al 2011, Chang et al 2011 , Li et al 2012b, Kim et al 2013, Yang et al 
2013), osteolytic bones (Nazarian et al 2008), regenerating (Ishimoto et al 2011)  
and normal bone tissues (Isaksson et al 2010a, Isaksson et al 2010b, Kim et al 
2010). As such, nanoindentation could aid in establishing a trend in intrinsic 
material property changes with disease progression.  
On the other hand, dynamic mechanical analysis could be used to measure 
tissue viscoelastic properties. Viscoelastic properties of material, including ability 
to dissipate energy (damping) and ability to recover from deformation, can be 
measured by dynamic mechanical analyzer (DMA) which applies an oscillating 
force on sample and obtains the resultant deformation. Depending on the material, 
the phase lag (δ) in resultant deformation could range from 00 to 900 (0 degrees 
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for purely elastic material, 90 degrees for purely viscous material). Tan δ could be 
derived, which reflects damping response of material and is a ratio of energy 
dissipated to energy stored in elastic component.  Tissue property dependence on 
strain rate can be estimated using a range of frequency scans over which 
oscillating force is applied (Dong et al 2004). By scanning in a range of 
frequencies, it can also provide information on active energy dissipation 
mechanisms in composite material since different energy dissipation mechanisms 
may be activated in a predictable range of frequencies (Yeni et al 2007). One 
advantage is that DMA facilitates for the testing of small samples, e.g. 
advantageous when using human cadavers and laboratory animals. 
Although not many studies have used dynamic mechanical analysis on 
viscoelastic assessment of diseased bone, it was found that damping response (tan 
δ) in ovariectomized sheep bone was greatly decreased (80%) and storage 
modulus was lowered (5.2%) (Les et al 2005).  While the disease mechanism 
between osteoporosis and osteolytic metastasis are not identical, both diseases 
presented overall enhanced bone resorption.  A similar alteration in viscoelastic 
property changes might be expected in osteolytic bone metastasis and could be 








1.3   Osteoblast changes due to metastatic cancer  
Emerging evidence from recent studies suggests that apart from increased 
RANKL expression and reduction in OPG expression by osteoblasts, there are 
more profound effects on osteoblasts due to metastatic cancer cells, which may 
explain the lack of new bone formation or healing reported in event of osteolytic 
metastasis even with bisphosphonate treatment (Mastro et al 2004).  
Mercer et al found that MC3T3- E1 osteoblasts cultured in MDA-MB231 
breast cancer cell- conditioned medium were unable to differentiate normally. The 
differentiation process typically involved the secretion of bone matrix materials 
such as alkaline phosphatase, osteopontin and sialoprotein, followed by 
mineralization in which osteocalcin is expressed and nodules are formed. They 
observed that there was down-regulation in sialoprotein and osteocalcin 
expression, no observable alkaline phosphatase activity and an apparent inhibition 
of in-vitro mineralization (Mercer et al 2004).   The inhibition on alkaline 
phosphatase activity and bone nodules was similarly observed for fetal carvarial 
cells exposed to 50% conditioned medium from MDA-MB-231(Zhu et al 2009).  
Morphological changes of the osteoblasts have also been observed in co-
culture with metastatic breast cancer cells, from cuboidal shape to a more 
elongated appearance. The change in morphology could be tied in with the 
observations of significant cytoskeleton reorganization where actin stress-fibers 
become clumped and punctuated (instead of forming smooth long fibers) and with 




        Studies done by Mastro et al on the other hand, found that exposure of 
human osteoblast line hFOB1. 19 to conditioned medium of MDA-MB-231 or 
MDA-MB-435 human metastatic breast cancer cells induced osteoblast apoptosis 
(programmed cell death); with an increase in terms of the percentage of apoptotic 
osteoblasts from 2% (normal culture of osteoblasts) to 8-12% by TUNEL assay 
(Mastro et al 2004).  
         In view of recent in-vitro studies, it could be seen that another contributing 
factor of bone loss in bone metastasis may be associated with the loss in normal 
function of osteoblasts and osteoblast apoptosis, on top of cytokine (biochemical 
signal) release from osteoblasts that promotes osteoclast activation (Dhurjati et al 
2008). There has been much focus on reducing tumour burden and inhibiting 
osteoclasts activity through the use of anticancer and antiresorptive treatments but 
fewer on the treatment of osteoblasts affected by metastatic cancer environment.  
Since osteoblasts are important for synthesizing bone matrix constituents 
as well as for bone homeostasis, it would be essential to investigate mechanisms 
by which osteoblasts are affected by metastatic breast cancer to help in 









1.3.1 A biomechanical approach to study bone cells         
 In this thesis, a biomechanical approach was adopted for the investigation 
of bone cells under the influence of metastatic breast cancer. This approach is 
intrinsically relevant as bone cells are mechanosensitive cells sensitized to 
changes in type, degree and duration of mechanical loading, giving rise to various 
biochemical responses which may affect tissue structure (Tanaka et al 2005, Li et 
al 2007, Ponik et al 2007, Kinder et al 2008). For example, it has been reported 
that cell stretching of human osteoblasts at intermittent loading (3 x 3h, 3 x 6 h, 
magnitude 1 %) resulted in up-regulation of RANKL, which increased osteoclast 
activity and subsequently bone resorption (Kreja et al 2008).  
  Based on the prior observations made of significant cytoskeletal change in 
osteoblastic cells exposed to the metastatic breast cancer conditioned medium, i.e. 
less actin stress fiber formation (Dhurjati et al 2008), it could be hypothesized that 
the cancer-affected bone cells would have changes in stiffness which could be 
quantified using the atomic force microscopic technique (AFM).  
AFM is a scanning probe based technique that is dependent on the 
interaction forces between the probe (AFM tip attached on cantilever spring) and 
the sample surface. It provides advantages of studying cells in its native biological 
environment in real time (Sokolov 2007), force sensitivity to the scale of 
piconewton (Lim et al 2006), nanoscale scanning resolution (Kuznetsova et al 
2007,  Sokolov 2007) and provides information about cell elastic and viscoelastic 
properties.   
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Stiffness of cancer-affected bone cells could be calculated using the Hertz-
Sneddon formula for spherical probe of radius R which has been adopted in many 
studies involving cells (Lekka et al 1999, Charras et al 2001, Jaasma et al 2006, 
Lim et al 2006, Kuznetsova et al 2007, Sokolov 2007, Bacabac et al 2008). The 
quantification of cell stiffness changes could be potentially used as an indicator of 
disease progression.  
On further note, the ability of osteoblasts to detect mechanical signals and 
respond with appropriate biochemical signals is dependent on the cytoskeleton, as 
suggested by key findings of prior research (Li et al 2007, Myers et al 2007). For 
instance through microfilament disruption, osteoblasts subjected to cyclical 
compression loading were found to be inhibited in terms of c-Fos mRNA and 
protein expression which are important for bone growth and mineralization (Li et 
al 2007).  It can therefore be further postulated that changes in osteoblast cell 
cytoskeleton could result in significant reduction in cell mechanosensing, 
mechanotransduction and bone remodeling events.   
  Mechanotransduction is a process involving the conversion of mechanical 
stimulus to biochemical or electrical signals through mechanosensing, signal 
transduction and effector cell (osteoblast and osteoclast) response (Papachroni et 
al 2009).  In bone, which functionally adapts its mass and structure according to 
mechanical loading, the osteocyte network and lacuno-canalicular porosity are 
believed to be main constituents facilitating mechanosensing (Burger 2001).   
Although the exact mechanisms are not known for certain, it has been 
demonstrated in an increasing number of studies that fluid flow (Chen et al 2000, 
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Myers et al 2007, Ponik et al 2007, Willems et al 2011), possibly through bone 
lacunar-canalicular porosity could mediate bone cells mechanosensing. High 
frequency, low magnitude vibration i.e. using vibration table, has also been 
employed in both in-vivo and in-vitro studies for stimulating bone (Rubin et al 
2002, Rubin et al 2004 , Ozcivici et al 2007, Wenger et al 2010), pre-osteoblast 
and stem cell differentiation (into osteoblasts) (Patel et al 2009, Ozcivici et al 
2010, Pre et al 2011) as well as bone cell osteogenic responses (Bacabac et al 
2006, Dumas et al 2010, Hou et al 2011).  
It has been reported that the earliest response of osteoblasts to mechanical 
loading or fluid stress is the rapid increase in calcium concentration within the 
cell, which triggers signals involved in mechanotransduction (Casimiro et al 
2009). Changes in nitric oxide (NO) levels were also monitored to assess the 
degree of bone cell activation, as NO is released by osteoblastic and osteocyte-
like cells with load stimulation (Vatsa et al 2006, McGarry et al 2008). 
Biochemical indicators in response to mechanical loading may thus be 
monitored to assess the differences in mechanosensitivity of the cells from tumour 
conditioned and non-conditioned groups. The changes in degree of 
mechanosensitivity of bone cells may also contribute towards the reduction in 







1.4   Overview of thesis and hypotheses 
In this thesis, a modified method of immunocompetent model of osteolytic 
metastases would be established. It is hypothesized that there would be changes in 
microstructural and intrinsic mechanical properties for sclerotic bone (disease 
regression), as arising from increased osteoblast activities. Characterization of 
bone responses using densitometric, microstructural and viscoelastic parameters 
would be carried out in the course of this work.  Viscoelastic properties were 
assessed using nanoindentation and dynamic mechanical analysis, with the former 
technique providing information on local material property changes arising due to 
changes in local cellular (bone formation) activity. 
It is also hypothesized that there would be changes in mechanical and 
mechanosensing properties of tumor-affected osteoblast cells.  To investigate the 
changes of bone cell mechanical property due to conditioning by primary tumour 
cells, atomic force microscopy indentation was utilized.  The mechanosensing 
changes in tumor affected bone cells were also examined by assessing nitric oxide 
level changes to low magnitude, high frequency vibration. By probing the 
changes in cell stiffness and in degree of mechanosensitivity of bone cells in vitro, 
it could serve to understand one mechanism by which the cellular level bone 
formation is affected in bone metastasis. This could be important in developing 







1) There would be changes in microstructural and intrinsic mechanical 
properties in sclerotic bone compared to normal bone. 
2) Variation in cell stiffness would occur due to tumor-conditioning, which 
also induced cell structural changes.   
3) Mechanosensing properties of bone cells to low magnitude, high 
frequency vibration would be altered by tumor conditioning.   
 
Research Contributions 
The current study which involved combination of in-vivo rodent model 
and in-vitro bone cellular studies would help to answer: 1) A clinical question: 
Partly to answer how sclerosis development could have arisen and how it would 
affect bone microstructural and intrinsic mechanical properties; 2) A scientific 
question: An important start to understanding the influence of tumor on the 
mechanical and mechanosensing properties of bone cells and examining the 
































2.1 Summary of Chapter 
  Establishing an immunocompetent model of osteolytic metastasis is 
important as the presence of immune system has an impact on the tumor 
promotion and suppression (Jaganjac 2008, Song et al 2008) and there is a 
significant cross-talk between tumour cells, immune cells and bone 
microenvironment (Bussard & Mastro 2009). Thus, it has been argued that an 
immunocompetent model of bone metastasis will be more appropriate in 
simulating disease progression (Coleman et al 2008).  
  While there has not been unequivocal evidence demonstrating 
immunocompromized models to be less realistic in simulating osteolytic 
metastases, it has also not been shown that sclerotic development could arise in 
immunocompromized models (Neudert et al 2003, Cowey et al 2007,  Arrington 
et al 2008, Chanda et al 2008, Ottewell et al 2008). On the other hand, it has been 
shown that there was spontaneous regression of tumor growth with presence of 
immune system in-vivo (Jaganjac 2008). Since it is our interest to examine 
sclerotic development which is a clinical sign of disease regression, it would be 
pertinent to adopt an immunocompetent model which could simulate both disease 
progression and regression phases. This chapter outlines the development, 
methodology and discussion of the immunocompetent model of osteolytic 






2.2  Development of model  
The surgical induction of osteolytic bone metastasis in an immune-
competent Sprague Dawley rodent model was modified after the method adopted 
by Kurth et al (Kurth & Muller 2001, Kurth et al 2001, Kurth et al 2007). It is 
selected for the advantages of tumour localization, which could facilitate for 
longer host survival and monitoring of tumour growth. Moreover, the use of rat 
mammary carcinosarcoma (W256 cells) provides some clinical relevance as they 
have characteristics similar to human breast cancer: poor immunogenicity and 
high metastatic ability (Badraoui et al 2009) as well as differential response to 
hormonal treatment (Blouin et al 2005). In addition, Kurth‟s methodology 
appeared to be repeatable over the years of 2000- 2001 and 2007.  
  In his method, 2 x 10
6
 Walker 256 rat breast carcinosarcoma cells were 
cultured in 0.6% agarose gel solution and the tumour cells in gel were surgically 
implanted into the medullary canal through a drill hole made in the intercondylar 
notch using an 18 gage needle. Kurth‟s method of drilling through the 
intercondylar notch was found to have destructive effects on the metaphyseal 
region, as a distinct drill hole (black arrow) was observed even at the time point of 





Figure 3: (A) Distinct drill hole made (black arrow) using 18G needle through 
intercondylar notch at 42 days time-point and (B) Surgical drilling using a 22G 
needle (black arrowhead). 
  A number of modifications were made to the technique: (1) change of the 
surgical insertion site to avoid drilling through the intercondylar notch (and in 
particular the distal metaphyseal area), (2) using a smaller needle size to reduce 
surgical damage, (3) increase in the number of cells used and (4) to inject cells 
without the use of the agarose gel (which is explained in subsequent paragraphs).  
In our modified technique, 8-10 weeks old female Sprague Dawley rats were 
subjected to anaesthesia and 10
7
 Walker 256 rat breast carcinoma cells (CCL-38, 
ATCC, USA) were suspended in 0.1 ml of medium and injected into the 
medullary cavity from an insertion site at least 5 mm away from the distal condyle 
(Figure 3B).        
  The modification of surgical insertion site to avoid drilling through the 
metaphyseal area has grounds based on literature. A study on the kinetics of 
metastatic human breast cancer cells migration in mice bone have found that the 
cancer cells were arrested mainly in the metaphyseal area within an hour of intra-
B A A 
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arterial injection and with preliminary evidences of cytokines favouring 
metaphyseal regions (Phadke et al 2006). Moreover, it was found that W256 cells 
have a higher growth rate adjacent to trabecular surfaces than when it is more than 
50 µm from bone (Kostenuik et al 1993). Thus, reducing the destructive effects of 
surgical drilling on the metaphyseal area, together with the increased cell density 
inoculated, is postulated to increase success of tumour adhesion and growth.  
        Preliminary testing with agarose gel mixed with cells at the stipulated 
concentration according to Kurth‟s protocol has yielded less satisfactory results. 
Trials to optimize agarose gel concentration (0.06%, 0.15%, 0.3%, 0.45%, 0.6%) 
with addition of tryptose phosphate broth (Li et al 1989) at 10%, 25%, 50%, 75%, 
100% v/v with culture medium have not been successful. W256 cells did not grow 
well in those conditions as shown in Figure 4. While 0.6% agarose with 10% 
tryphase phosphate broth gel sandwich layer demonstrated the best gelling 
property and cell compatibility among the different combinations, the cell 







Figure 4: W256 cells in gel sandwich, with 0.6% agarose and 10% tryphase 
phosphate broth as bottom layer as well as 0.6% agarose top layer. 
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      As such, direct inoculation with cells was used without agarose gel, but with a 
higher cell concentration to increase chances of inoculation that might be reduced 
by in-vivo conditions e.g. blood flow out of the surgical site. 
 
2.3 Methodology 
Immunocompetent rat model of osteolytic metastases 
Thirty nine Sprague Dawley (SD) female rats, 8 -10 weeks old 
(Laboratory Animal Centre, National University of Singapore) were housed at 
25
o
C with a 12:12 hour light-dark cycle and were given standard rodent diet 
(Harland, Model T.2018S) and water ad libitum. All animal experiments were 
conducted in accordance with an approved protocol from Institutional Animal 
Care and Use Committee (IACUC) at National University of Singapore. Surgical 
procedures were carried out after 5 days of acclimatization of the rats at animal 
housing unit. The rats were randomly divided into 2 groups: one group (EXP, 
n=30), was subjected to surgical inoculation of 10
7
 W256 cells (ATCC, USA) in 
0.1 ml M199 culture medium into the medullary cavity of left femur using a 22G 
needle, while the right femur was kept intact (Chen et al 2013a). The other group 
(SHAM, n=9) was surgically inoculated with M199 culture medium into the left 
femur while the right femur was kept intact.   
 
Radiography 
At 10 days interval, rats were subjected to in vivo scanning using Kodak 
X-ray system (Carestream Health Inc, USA), at 35kV tube voltage, 0.3mA current 
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and 2 mins exposure time. X-ray analysis was performed with radiological scores 
given as follows; 0 for no radiolucent lesion observed, 1 for minimal but 
detectable lysis, 2 for moderate lysis limited to medullary cavity, 3 for extensive 
lesions extending into soft tissues (Mann et al 2008). Sclerotic bone formation is 
identified by calcified regions within the medullary and labeled as SCL. Two 
examiners have graded the radiographs on independent occasions without 
specimen labelings.  Based on the radiographic indication of sclerotic 
development, some of the rats from the EXP group were allotted to the sclerotic 
response group (SCL, n=15).  The remaining 15 rats showed either varying 
osteolytic (n=7), mixed osteolytic and sclerotic (n=2) or no lesion responses (n=6).  
 
Histological analyses 
Histological analyses were performed on paraffin embedded bone using 
Hematoxylin and Eosin (H&E) staining for signs of tumor proliferation and bone 
cell response.  The remaining rats from osteolytic groups LYTIC (n=6) and 
SHAM groups (n=9) were sacrificed at 50 days post-surgery and both femurs 
were harvested. The bones were wrapped in gauze soaked with phosphate 
buffered saline (PBS), stored at -20
0
C until used for experiments. Prior to testing, 





 Geometric and densitometric properties of left-operated femurs and right 
intact femurs from both SHAM and LYTIC groups were measured using 
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peripheral quantitative computed tomography (pQCT) (XCT Research SA+; 
Stratec, Germany). The bone was scanned from 1mm above the distal 
metaphyseal growth plate as determined from a prior scout scan, using a voxel 
size of 100µm. The metaphyseal region is of interest because any modeling and/or 
repair of osteolysis, typically associated with trabecular bone loss (Mann et al 
2008), could be best assessed at the trabecular rich metaphyseal area. All 
measurements were averaged across 4 cross-sectional slices, each with a thickness 
of 0.5mm and slice-to-slice distance of 0.75mm. A threshold of 280 mg/cm
3
 was 
used to separate bone from soft tissue and inner threshold of 550 mg/cm
3
 was 
used to separate trabecular bone from sub-cortical and cortical bone during the 
analysis (Chen et al 2013a, Yang et al 2011).  Bone mineral density (BMD), bone 
mineral content (BMC), cortical and trabecular density and bone area were 
calculated for both femurs of each animal.     
 
Micro-CT analysis  
The distal femoral metaphysis was scanned using the SkyScan micro-CT 
machine (SkyScan 1172, Konitch, Belgium) with standardized settings of 
100KeV peak energy, 18µm nominal resolution, with a fixed source to object 
distance of 121 mm and source to detector distance of 161 mm. The region of 
interest (ROI), containing 200 micro-CT slices, was scanned from 1mm above the 
distal metaphyseal growth plate, same as pQCT scans. The images were then 
analyzed using the CT Analyser program (Skyscan, Belgium). A semi-automated 
contouring method was employed to select trabecular from cortical bone and the 
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morphological indices, namely bone volume fraction (BV/TV), bone surface 
density (BS/TV), trabecular number (Tb.N), trabecular separation (Tb.Sp), 
trabecular thickness (Tb.Th) and structure model index (SMI) were obtained.  
 
Nanoindentation Testing 
 Thawed femur bones were rehydrated for 16 hours and then embedded in 
epoxy resin (Struers, USA) overnight, with the femur positioned upright (Fig. 5A).  
The embedded sample was cut precisely using a diamond blade (Isomet 1000 
precision saw, Buehler, USA) at approximately 2.5 mm from the distal end of the 
femur (Fig 5B) to expose the metaphyseal growth plate and rehydrated overnight.  
  
Figure 5: (A) Epoxy embedding of femur sample and (B) sample sectioned at 
2.5mm from distal end  
The bone was then ground using a series of grinding paper with increasing 
fineness: 320, 500, 1200 and 4000; then polished using micro-bead suspensions of 
3µm followed by 1µm. The sample height was monitored to ensure that 
indentations were made within the same region of interest (ROI), i.e. 1mm above 






were placed in the testing chamber at room temperature for 2 hours prior to 
indentation to achieve thermal stabilization (Ishimoto et al 2011). A pyramidal 
Berkovich tip was used to indent on the bone specimen using dynamic loading i.e. 
continuous stiffness mode (CSM) (G200 nanoindentor, Agilent, US).  
The CSM mode superimposes small oscillation amplitude Z0, which is a 
constant of two nanometers, on loading signal at 45Hz. As size of contact 
increases, force oscillation amplitude, F0 increases as well to maintain the 
constant displacement oscillation amplitude. Thus, CSM provides a continuous 
calculation of indentation modulus (E) and indentation hardness (H) based from 
amplitude ratio (F0 / Z0) (Yang et al 2013). This differed from traditional quasi-
static method that yields only one value of E and H at maximum depth (Huja et al 
2010).   
Specifically, indentation modulus (E) is defined (Herbert et al 2008) as:  
 













 ...………………………Equation (1) 
Where  is phase angle between the applied load and resulting displacement,  
=1.034 for Berkovich tip (Herbert et al 2008), ν is Poisson‟s ratio and A is the 
projected contact area.  
On the other hand, hardness (H) is defined as:  
    
 
 
 ……………………………………………Equation (2) 
Where P is the load applied to sample surface and A is the projected 
contact area 
A total of 50 indentations of maximum indentation depth of 1200 nm were 
carried out on the trabecular and cortical regions. Neighboring indents were 
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spaced more than 60µm apart and indentations were placed away from the 
cortical bone/epoxy interface in order to minimize interference due to penetration 
by epoxy.  E and H were determined at a depth of 700-800nm, to avoid 
interference due to surface roughness.   
In this study, bone was assumed to be isotropic (Zysset et al 1999) with 
Poisson ratio of 0.3 (Kim et al 2013, Huja et al 2010, Zysset et al 1999).  An 
isotropic material is homogenous in all directions for mechanical properties and 
other physical properties (Lespessailles et al 2006). In contrast, bone is an 
anisotropic material (Hofmann et al 2006) but indentations on different 
anatomical locations within transverse section of femoral bone (medial, lateral, 
anterior, posterior) have indicated that there were no comparative differences 
between groups. This suggested that bone material could be assumed to be 
isotropic at nano-level in the longitudinal direction. The assumption made for 
compressibility is similarly acceptable since sensitivity studies have indicated that 
the error of E associated with the variation of Poisson ratio (within 0.2-0.4) to be 
less than 10% (Rho et al 1997, Zysset et al 1999). 
A separate creep test was carried out in the cortical and trabecular regions 
at a maximum load of 6.3mN and hold time of 400s. The indenter tip was then 
unloaded to 10% of the maximum load and held another 50s for thermal drift 
measurement. Viscosity (η), which is defined as a parameter reflecting viscous-
like deformation in a solid under loading, was evaluated using Equation (3) (Kim 





























where h(t) is the creep displacement under maximum load as a function of time, α 
is an equivalent cone semi-angle (70.3°) to the face angle of the Berkovich 
indenter (65.27°), E is an elastic element of the Voigt model (separately derived 
from the creep test) and Po is the maximum load.  Figure 6 showed good 
experimental fitting of bone creep response using Voigt model by non-linear least 
squares regression (R
2
 >0.99 for all indentations).  
 











2.4  Discussions of the model 
One of the primary identifications for bone metastases included bone 
radiography, which is a standard for differentiating bone lesions (Salvo et al 
2009). Osteolytic lesions give a radiolucent appearance due to the destruction of 
bone and could be associated with or without sclerosis (tissue hardening) 
formation (Priolo & Cerase 1998). Sclerosis (tissue hardening) development is 
typical of benign or slow growing lesions, with new and reactive bone formation 
about the lesion area (Priolo & Cerase 1998).    
Through preliminary diagnosis using radiography, it was estimated that 
out of 30 rodents, 15 had sclerotic response, 7 had highly variable osteolytic 
effects, 2 presented mixed effect and 6 had no visible bone response. There were 
no reactive bone changes as a result of the operation, as shown by the sham-
operated bone (Fig. 7A). The animal model presented a highly variable osteolytic 
effect i.e. with 1 rat having extensive radiolucent lesions and fracture (Fig. 7B) 
and 6 rats with minimal lysis (Fig. 7C). Sclerotic response (Fig. 7D) was the 
predominant response over other responses (osteolytic, mixed and no response), 
which was illustrated by highly calcified tissues extending into the medullary 
cavity.   
Since earlier models of both immunocompetent and immunocompromized 
models of osteolytic metastases have typically presented mainly osteolytic 
responses (Sasaki et al 1995, Hiraga et al 2001, Kurth et al 2001, Neudert et al 
2003, Kurth et al 2007, Zheng et al 2007), there has been no prior report of 
sclerotic development. As such, even though quantitatively, there was only up to 
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50% chance of sclerotic response, it was interpreted to be a predominant response 
over other 3 types of possible responses in this model.  
Figure 7: (A) Radiographical examination of different bone responses induced in 
this model: SHAM with no reactive bone response, (B) Osteolytic (Score 3) with 
soft tissue tumor burden, (C) Osteolytic (Score 1) with minimal but detectable 
lesion and (D) SCL with tissue hardening (white arrowheads). 
Histological examination has yielded similar results, with 1 rat having 
aggressive osteolytic tumor burden at the metasphyseal region (Fig. 8), while 
majority presented stages of tumor regression. Tumor cells were being eliminated 
as early as 10 days for rats presenting a sclerotic response (Elaboration under 
Chapter 3).  The mechanism for a spontaneous W256 tumor regression was not 




Figure 8: Tumor cells infiltration into soft tissue (*) and fragmented distal 
metaphyseal growth plate (black arrow).  
The variability in tumor growth rates could thus possibly indicate the 
involvement of the adaptive immune response.  Moreover, it was possible that 
only a small percentage of the heterogeneous tumor cells possess the molecular 
signature for bone metastasis (Li et al 2008) that could contribute to varying 
degrees of osteolysis.  
Since majority of the osteolytic samples have radiological score of 1 (i.e. 
6/7), these rats constituting the LYTIC group (n=6) were used for in-vitro analysis. 
Rat with soft tumor burden (with soft tumor excised) was used for establishment 
of primary tumor culture for experiments under Chapter 4 and 5.   
pQCT results have indicated that there was significant decrease in 
trabecular content (-28.7%, p=0.006) for LYTIC group (n=6) compared to SHAM 
group (n=9) as observed from Table 1.  Since osteolysis gives rise to considerable 
trabecular bone loss before cortical bone integrity is affected (Mann et al 2008), 





bone volume and microstructure.  Nevertheless, no significant differences 
between both groups in terms of trabecular microstructure were found from 
micro-CT (Table 1). It is plausible that the LYTIC group presented cases of 
micrometastases, of which micro-CT could have failed to diagnose. Since micro-
CT provided a pixel resolution of 18µm which was in the size range of the 
resorption pits (Chappard et al 2010), a higher resolution micro-CT could assist in 
providing better diagnosis.   
On the other hand, BMD, BMC and weight of LYTIC group were still 
significantly higher than SHAM group. It has been reported that BMD (Kurth et 
al 2002, Medhurst et al 2002, Alvarez et al 2003, Fritz et al 2007), BMC 
(Medhurst et al 2002) and microstructural indices (Kurth & Muller 2001, Fritz et 
al 2007, Badraoui et al 2009) decreased significantly with increased tumor burden. 
It was also duly observed that rat with increasing tumor burden appeared to have 
weight loss and mobility issues. Thus, based on the combined assessment from 
pQCT, micro-CT and weight changes, the osteolytic effect in the LYTIC group is 
likely minimal (low tumor burden), which is in accordance with radiological score 
of 1.  
There could be a possibility that some samples constituted a false positive 
e.g. up to 2% based on X-ray diagnosis (Tudor et al 1997). However, all the bones 
have been included regardless, since the preliminary diagnoses have indicated 
positive.  As such, it was essential for a number of complementary imaging 




Table 1.  Densitometric, microstructural parameters and weight at 50
th
















)  795.8 ± 33.0
 a, b










1051.4 ± 80.1 1045.7 ± 83.1 1056.8 ± 111.1 1068.9 ± 91.3 
BMC (mg/cm) 16.2 ± 3.30
 a ,b












 20.2 ± 3.03
 
 19.1 ± 3.79 19.2 ± 3.70 
BV/TV (%) 13.1 ± 1.52 16.0 ± 3.89 11.5 ± 6.22 13.6 ± 5.97 
BS/TV 
(1/mm) 
4.24 ± 0.3 5.11 ± 0.94 3.63 ± 1.49 
4.31 ± 1.35 
Tb.N (1/mm) 0.93 ± 0.11 1.15 ± 0.24 0.77 ± 0.34 0.97 ± 0.34 
Tb.Th (mm) 0.14 ± 0.002 0.13 ± 0.006 0.14 ± 0.02 0.13 ± 0.015 
Tb.Sp (mm) 0.59 ± 0.10 0.56 ± 0.13 0.73 ± 0.22 0.64 ± 0.16 
SMI 2.53 ± 0.22 2.37 ± 0.13 2.64 ± 0.29 2.43 ± 0.30 
Weight (g) 308.3 ± 26.7
 c
 277.5 ± 21.1 
 
a
 Significant difference from SHAM  (Operated LF) (p<0.05) by one-way 
ANOVA , Bonferroni post hoc analysis.  
 
b
 Significant difference from SHAM (Intact RF) (p<0.05) by one-way ANOVA, 
Bonferroni post hoc analysis 
c
 Significant difference from SHAM (p<0.05) by paired t-test, p <0.05 
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Local nanomechanical property changes of LYTIC group on the other 
hand, have shown a significant decrease in cortical hardness (-13.3%) and a 
general trend of decrease across other parameters with the exception of trabecular 
viscosity ηt (which was slightly higher) as compared to SHAM (Table 2).  
Metastatic cancer affected trabeculae has been shown to have a significant 
decrease (-50%) in local tissue hardness Ht and in elastic modulus Et (Nazarian et 
al 2008). Thus, the trend of reduced elastic mechanical properties observed from 
nanoindentation results appeared to be in agreement, except that it was cortical 
hardness that was significantly changed and not trabecular hardness. It was a little 
unexpected since osteolysis effects are more likely to affect trabecular bone faster 
than cortical bone (Mann et al, 2008) and it was trabecular content which was 











Table 2. Nanomechanical property changes of LYTIC and SHAM as measured by 




 day after surgery  





Ec 16.38 ± 3.31 16.45 ± 2.68  
(GPa)    
    
Et 13.85 ± 3.00
 
 14.03 ± 1.56  
(GPa)    
    
Hc 0.52± 0.15
 a
 0.60 ± 0.14
 b
  
(GPa)    
    
Ht 0.54± 0.16 0.56 ± 0.12  
(GPa)    
    
ηc 27456 ±  11234 30370 ± 10555
 
  
(GPa S)    
    
ηt 28203 ± 10166  27870 ± 8111
 
  
(GPa S)    
 
Ec = cortical elastic modulus, Et = trabecular elastic modulus, Hc = cortical 
hardness, Ht = trabecular hardness, ηc = cortical viscosity, ηt = trabecular viscosity, 
LF = Left Femur, RF = Right Femur.  
Statistical Test: One way ANOVA with Bonferroni corrections (SPSS v.16)   
a
 Significant difference from SHAM  (Operated LF) (p<0.05)
 
b








It could be that there is a need for longer time for the manifestation of 
osteolytic effect for these rats with lower tumor growth rates.  The model thus has 
its limitations in terms of reproducibility i.e. high variability in osteolytic lesions 
and limited tumor cell survival which depended on escaping immune surveillance 
and forming symbiotic interactions with host cells (Fidler 2003).  
On the other hand, since the model provides sclerotic response, it could be 
ideal for examining sclerosis development (Chapter 3). With a primary tumor 
culture derived from in-vivo model, the direct effects of primary tumor cells on 
bone cells mechanical properties (Chapter 4) and mechanosensing (Chapter 5) 

















Chapter 3: Sclerotic response of bone tissue in 















3.1  Summary of Chapter 
Sclerosis (tissue hardening) development is a common occurrence in slow 
growing or benign osteolytic lesions. However, there is lack of knowledge on the 
mechanical and material property changes associated with sclerotic bone response.  
The immune system is postulated to play a relevant role in evoking sclerotic bone 
responses. In this chapter, localized sclerotic response in an immunocompetent 
model of Walker 256 breast carcinoma in SD rats showed a healing flare, with 
subsequent increase in new reactive bone formation. Sclerotic rat femurs showed 
significant increases in bone mineral density (BMD), bone mineral content 
(BMC), bone volume fraction (BV/TV), bone surface density (BS/TV), trabecular 
number (Tb.N) and a significant decrease in trabecular separation (Tb.Sp) and 
structural model index (SMI) as compared to control rat femurs. Significantly 
reduced creep responses were observed for both trabecular and cortical bone in 
sclerotic bones while no significant difference were observed in elastic modulus 
(E) and hardness (H) values, despite the active modeling. Therefore, we conclude 
that viscoelastic creep property using nanoindentation would serve as a more 
sensitive indicator of localized bone modeling than the elastic properties. 
Although enhanced microstructural changes and increased BMD contributes 
towards increased bone strength, reduced viscoelasticity could contribute towards 
increased microcrack propagation and therefore a reduced toughness. Since 
significant positive correlations between elastic properties (E) and (H) with 
viscosity () were also found, we can conclude that mechanical behavior of 
46 
 
sclerotic bone could shift towards a material with lowered damping and increased 
stiffness.    
  
3.2  Introduction 
For slow growing or benign lytic lesions, sclerosis (tissue hardening) 
development is a frequent occurrence (Priolo, & Cerase 1998) . In a study of 274 
patients over 10 years, regression indicators in osteolytic bone metastasis based 
on radiological analysis were found to be recalcification of the lesion (11.6%), 
foci of sclerosis around the lesion (13.5%) which are apparent as low calcified 
spots and lack of deterioration of lesion (10.5%) over a period of at least 12 
months (Huber et al 2002). Although sclerosis development in bone is seemingly 
favorable, little is known regarding its mechanism or its intrinsic material and 
mechanical property changes. 
Bone is a hierarchical composite material comprising of macroscale bone 
cortex - trabeculae structure, microscale osteons - lamellae structure and 
nanoscale collagen fibers - hydroxyapatite crystals (Richie et al 2009, Chang et al 
2011).  As a composite material, bone exhibits viscoelastic behavior across 
different scales. Nanoindentation techniques could be used to study local tissue 
viscoelasticity, by analyzing the creep effect of the bone under constant load 
using rheological models such as Burger (Isaksson et al 2010a, Isaksson et al 
2010b) and Voigt models (Kim et al 2013, Yang et al 2013, Kim et al 2011).  It 
has already been used to monitor localized nanomechanical property changes in 
osteolytic bones (Nazarian et al 2008).  Nano-level elastic properties could also be 
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assessed using semi-dynamic (Isaksson et al 2010a, Isaksson et al 2010b) and 
dynamic loading methods (Pathak et al 2011).  
Dynamic mechanical analyses could be used after nanoindentation to 
assess tissue viscoelasticity from machined sections of bone. By monitoring tan δ 
(ratio of energy dissipated to energy stored in elastic component) across a range 
of frequencies, the comparative changes in tissue damping property could be 
provided. Together with peripheral quantitative computed tomography (pQCT) 
(Gasser 1995, Jamsa et al 2000) and micro-CT, these techniques could be used to 
assess the degree of bone repair and modeling occurring in sclerosis.  
This chapter aims to assess the sclerotic response in an immunocompetent 
rodent model in terms of histological assessment, densitometric, micro-
architectural indices and intrinsic tissue mechanical properties. It is a pertinent 
issue since changes in intrinsic material properties may affect the tissue level 
quality and strength. To the best of our knowledge, this is the first chapter to 
study the sclerotic response in an immunocompetent model of breast cancer 
inoculated into bone. The presence of the immune system in the animal model is 
postulated to play a relevant role in evoking sclerotic bone response.   
The objectives of this chapter are therefore to: (1) characterize 
histomorphometric, densitometric, microarchitectural, elastic and viscoelastic 
property changes in a localized sclerotic response in an immunocompetent rat 
model and (2) to study whether viscoelastic nanomechanical properties can be 




3.3  Methodology 
Immunocompetent animal model   
 Thirty nine Sprague Dawley (SD) female rats, 8 -10 weeks old 
(Laboratory Animal Centre, National University of Singapore) were housed at 
25
o
C with a 12:12 hour light-dark cycle and were given standard rodent diet 
(Harland, Model T.2018S) and water ad libitum. All animal experiments were 
conducted in accordance with an approved protocol from Institutional Animal 
Care and Use Committee (IACUC) at National University of Singapore. Surgical 
procedures were carried out after 5 days of acclimatization of the rats at animal 
housing unit. The rats were randomly divided into 2 groups: one group (EXP, 
n=30), was subjected to surgical inoculation of 10
7
 W256 cells in 0.1 ml M199 
culture medium into the medullary cavity of left femur using a 22G needle, while 
the right femur was kept intact (Chen et al 2013a). The other group (SHAM, n=9) 
was surgically inoculated with M199 culture medium into the left femur while the 
right femur was kept intact.  Based on preliminary radiographical diagnosis, 15 
out of 30 in EXP group exhibited sclerotic bone responses and were allocated to 
SCL group (n=15). 
 
Histological analyses 
2 rats from SCL group were euthanized at 10 days interval until 50 days 
post-surgery and their femur bones were subjected to histological assessment.  
Histological analyses were performed using H&E staining for signs of tumor 
proliferation and bone cell response. While n=2 rats is insufficient to account for 
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inter-rat variability, histological analyses were meant to qualitatively shed light on 
the role of immune system, tumor cells and bone cells on the development of 
sclerosis. Given the limited number of samples, n=2 per time point was assigned. 
Additional Masson trichrome staining of collagen in a 50 days post-surgery SCL 
bone sample was performed by the Advanced Molecular Pathology Laboratory, 
IMCB, A*STAR, Singapore.     
The remaining rats from SCL (n=5) and SHAM groups were sacrificed at 
50 days post-surgery and both femurs were harvested. The bones were wrapped in 
gauze soaked with phosphate buffered saline (PBS), stored at -20
0
C until used for 






 Geometric and densitometric properties of left-operated femurs and right 
intact femurs from both SHAM and SCL groups were measured using peripheral 
quantitative computed tomography (pQCT) (XCT Research SA+; Stratec, 
Germany). The bone was scanned from 1mm above the distal metaphyseal growth 
plate as determined from a prior scout scan, using a voxel size of 100µm. The 
metaphyseal region is of interest because any modeling and/or repair of osteolysis, 
typically associated with trabecular bone loss (Mann et al 2008), could be best 
assessed at the trabecular rich metaphyseal area. All measurements were averaged 
across 4 cross-sectional slices, each with a thickness of 0.5mm and slice-to-slice 
distance of 0.75mm. A threshold of 280 mg/cm
3
 was used to separate bone from 
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soft tissue and inner threshold of 550 mg/cm
3
 was used to separate trabecular 
bone from sub-cortical and cortical bone during the analysis (Chen et al 2013a, 
Yang et al 2011).  Bone mineral density (BMD), bone mineral content (BMC), 
cortical and trabecular density and bone area were calculated for both femurs of 
each animal.    
 
Micro-CT analysis  
The distal femoral metaphysis was scanned using the SkyScan micro-CT 
machine (SkyScan 1172, Konitch, Belgium) with standardized settings of 
100KeV peak energy, 18µm nominal resolution, with a fixed source to object 
distance of 121 mm and source to detector distance of 161 mm. The volume of 
interest (VOI), containing 200 micro-CT slices, was scanned from 1mm above the 
distal metaphyseal growth plate, same as the pQCT scans. The images were then 
analyzed using the CT Analyser program (Skyscan, Belgium). A semi-automated 
contouring method was employed to select trabecular from cortical bone and the 
morphological indices, namely bone volume fraction (BV/TV), bone surface 
density (BS/TV), trabecular number (Tb.N), trabecular separation (Tb.Sp), 
trabecular thickness (Tb.Th) and structure model index (SMI) were obtained. The 
degree of anisotropy (DA), which is defined as the ratio of the longest to the 
shortest axis of the ellipsoid could also be determined (Whitehouse 1974).  Three-
dimensional CT rendered images were obtained at a higher nominal resolution of 
9 µm using adaptive rendering algorithm by using the ANT program (Skyscan, 




 Thawed femur bones were rehydrated for 16 hours and then embedded in 
epoxy resin overnight, with the femur positioned upright.  The embedded sample 
was cut precisely using a diamond blade to expose the metaphyseal growth plate 
(Isomet 1000 precision saw, Buehler, USA) and rehydrated overnight. The bone 
was then ground using a series of grinding paper with increasing fineness: 320, 
500, 1200 and 4000; then polished using micro-bead suspensions of 3µm 
followed by 1µm. The sample height was monitored to ensure that indentations 
were made within the same ROI, across different samples. Embedded femur 
specimens were placed in the testing chamber at room temperature for 2 hours 
prior to indentation to achieve thermal stabilization (Ishimoto et al 2001). A 
pyramidal Berkovich tip was used to indent on the bone specimen using 
continuous stiffness mode (CSM) (G200 nanoindentor, Agilent, US). This 
dynamic mode of indentation superimposes a small oscillation at 45Hz, 0.01s
-1
 on 
loading signal, to provide a continuous measure of elastic modulus (E) and 
hardness (H) up to a maximum indentation depth of 1200 nm.  
A total of 50 indentations were carried out on the trabecular and cortical 
regions, where neighboring indents were spaced more than 60µm apart. 
Indentations were placed away from the cortical bone/epoxy interface and 
towards the inner cortex in order to minimize interference due to penetration by 
epoxy.  E and H were determined at a depth of 700-800nm, to avoid interference 
due to surface roughness. Thermal drift was corrected for each indentation 
experiment, by calculating the drift rate due to thermal expansion or contraction 
52 
 
in the test material or equipment, near the end of each experiment. In this study, 
bone was assumed to be isotropic with Poisson ratio of 0.3.    
A separate creep test was carried out in the cortical and trabecular regions 
at a maximum load of 6.3mN and hold time of 400s. The indenter tip was then 
unloaded to 10% of the maximum load and held another 50s for thermal drift 
measurement. Viscosity (η), which is defined as a parameter reflecting viscous-
like deformation in a solid under loading, was evaluated using Equation (3) below 




























where h(t) is the creep displacement under maximum load as a function of time, α 
is an equivalent cone semi-angle (70.3°) to the face angle of the Berkovich 
indenter (65.27°), E is an elastic element of the Voigt model and Po is the 
maximum load. 
Pearson‟s correlations were established between η and E values and 
between η and H values.  The indentations for creep and CSM modes were 
distanced sufficiently close to each other for a valid correlation.  
 
Dynamical Mechanical Analysis 
 Rectangular strips of cortical bone in the posterior section (width 1.55 ± 
0.05 mm, thickness 0.35 ± 0.018mm) were sectioned from earlier nanoindentation 
samples, with SHAM (n=5) and SCL (n=4) .  The bones were tested in single 
cantilever bending (Fig. 9A) with a span of 5mm, in phosphate buffered saline 
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solution at 37ºC using a Dynamic mechanical analyzer (DMA8000, Perkin-Elmer, 
USA). Each bone was tested in triplicates, with at least 40 min between each test, 
which consisted of a frequency scan from 0.01 to 20 Hz. Dynamic mechanical 
analysis assesses viscoelastic properties of bone by applying oscillating stress σ 
(Fig. 9B) with angular frequency ω to a material (Equation 4). Resulting strain ε 
was then recorded as with Equation 5.     
  
Figure 9: (A) Dynamic mechanical analyzer single cantilever set up, showing 
fixation of the cortical bone section (black arrow) and (B) Sinusoidal stress 
applied on linear viscoelastic material and showing phase lag δ. 
 
Equations (Les et al 2005):  
ζ = ζo cos ωt …………………………………….. (4) 
Measured strain ε:  
    ε = εo cos(ωt - δ) ………………………………… (5) 




where δ is the phase angle between stress σ and strain ε in response to a sinusoidal 
stress σ (t)  as shown in Figure 9B. The complex modulus of the material under 
these conditions, E* can be defined as 
E* = E’ + iE” …………………………………… (6) 
where E’ is the real or storage modulus (approximated to the Young's modulus ) 
E’ = (ζo/εo) cos δ ………………………………… (7) 
and E” is the loss modulus: 
E” = (ζo/εo) sin δ ………………………………… (8) 
The loss tangent, or tan δ, is defined as  
tan δ = E”/ E’ ……………………………………. (9) 
Tan δ that indicates amount of energy dissipated relative to energy stored 
in elastic component (Yeni et al 2007) may then be derived using Equation (9). 
There is an implicit assumption of bone being a linearly viscoelastic material 
which is not reflective of true bone material property.  Nonetheless, it was 
adopted as a model in DMA to assess changes in viscoelastic responses in control 
and test samples.  
Statistical analysis 
 All statistical analysis was conducted using SPSS v16, with results 
reported as mean ±SD (standard deviation). One-way ANOVA analysis (p<0.05) 
for SHAM, SCL groups were carried out with post-hoc tests of Bonferroni for 
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equal variances and Tamhane‟ T2 for unequal variances. Bivariate linear 
Pearson‟s correlation coefficients were also established with p<0.05 (2 tailed) for 
significance. For DMA results, paired t-test was used for comparisons between 
SHAM and SCL bone per frequency point, with p<0.05 (2 tailed) for significance.   
 
3.4 Results 
Different responses of bone metastasis 
A combination of factors including different host conditions and 
heterogeneity in metastatic potential of tumor cells induces different bone 
responses (Nicolson & Poste 1983). In the group surgically inoculated with W256 
cells (n=30), there were predominantly sclerotic response (n=15), variable 
osteolytic effect (n=7), mixed (n=2) and no responses (n=6) based on preliminary 
radiography examinations. 
As observed from histological assessment (Fig. 10A), a cascade of healing 
activities involving osteoblast cells was observed at the 10
th
 day post-surgery for 
sclerotic group. Presence of any prominent inflammatory response to W256 cells 
appeared to have receded by 10
th
 day. As shown in Fig. 10B, there were no signs 
of tumor cells on day 50 post-surgery (or at earlier time-points) for sclerotic 
femurs but there were active osteoblastic cells which formed immature bone 
extending to the medullary cavity. The lamellar bone tissue in this region of 
interest displayed no qualitative difference in collagen organization from the 




Figure 10: (A) Healing cascade (black arrows) at 10
th
 day at 20x magnification; 
(B) Immature bone formation and osteoblasts activity (black arrows) at 50
th
 day, 
10x magnification for sclerotic bone and (C) Collagen staining (white arrows) of 
sclerotic bone at 50
th
 day, at 10x magnification with Masson‟s Trichrome stain. 
 
Densitometric and morphological changes  
Fig. 11A shows 4 sequential slices of pQCT rendered images of distal 
femur where an infiltration of bone (indicated by white and highly mineralized 
regions) into the medullary cavity was prominent in sclerotic femur at 50 days. 
This was increasingly obvious in slices closer to the diaphyseal region. Fig. 11B, 
C and D represents averaged BMD, BMC and trabecular density of SHAM and 
SCL groups at 50
th
 day. Significant increases in BMD (+12.8%, p<0.001) and 
BMC (+17.4%, p=0.039) were found in the SCL femur as compared to SHAM 
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femur. Trabecular density was observed to have increased in SCL bone but this 
increase was not significant (+6.42%, p=0.236). Cortical density (+0.14%, p=1.0) 
and bone area (+4.31%, p=1.0) of both groups (SCL compared to SHAM) were 
not significantly different from each other.   
 
Figure 11: (A) pQCT sequential sections at metaphyseal region showed 
infiltration of new bone into the medullary for SCL bone in sections closer 
towards diaphyseal region, (B) Bone Mineral Density (BMD), (C) Bone Mineral 
Content (BMC) and (D) mean Trabecular Density. * -indicated p<0.05, one way 




Fig. 12 shows the micro-CT rendered image of SHAM and SCL femurs 
with a nominal resolution of 9 µm. It was observed that there was an increase in 
trabecular bone structure and volume in the medullary region of SCL bone as 
compared to SHAM bone.  
 
 
Figure 12: Micro-CT images of SHAM and SCL, with isotropic voxel at 9µm. 
SCL showed enhanced trabecular microarchitecture (arrows) compared to SHAM. 
 
Fig.13 shows the microstructural indices for SHAM and SCL group for 
mean BV/TV, BS/TV, Tb.N, Tb.Th, Tb.Sp and SMI. Significant increases in 
BV/TV (+179.3%, p<0.001), BS/TV (+83.3 %, p=0.002), Tb.N (+99.3%, p=0.001) 
and decreases in Tb.Sp (-48.9%, p=0.006) and SMI (-29.1%, p=0.001) were 
observed in SCL left femurs as compared to the SHAM left femurs. An increase 
in Tb.Th was also observed in SCL left femur, but the difference was not 
significant (+321.1%, p = 0.886). Similarly, there was no significant difference in 
degree of anisotrophy between SHAM (2.81  0.45) and SCL left femur groups 
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(2.66  0.19). It also indicated that trabecular microstructure in both groups were 
anisotropic.  
On the other hand, as shown in Table 3, the mean linear attenuation 
coefficient (per pixel) of SCL bone was significantly higher than that of SHAM 
for trabecular bone (+ 7.76%, p = 0.026) and not significant for cortical bone (+ 
4.13%, p = 1.0). 
Figure 13: Micro-CT indices of SHAM and SCL: Bone volume fraction (BV/TV), 
Bone surface density (BS/TV), Trabecular number (Tb.N), Trabecular thickness 
(Tb.Th), Trabecular separation (Tb.Sp) and Structural model index (SMI). * 
indicated  p<0.05   
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Nano-level elastic and viscoelastic properties 
There were no significant differences found in either cortical or trabecular 
E and H values between SCL and SHAM operated bones (Table 3).  
 
Table 3. Nanomechanical properties changes and mean linear attenuation 




 day after surgery  








     
Ec (GPa) 16.45 ± 2.68 16.19 ± 2.92 16.79 ± 2.92 16.16 ± 2.67 
     
Et (GPa) 14.03 ± 1.56 14.27 ± 2.33 14.51 ± 2.87 13.77 ± 2.51 
     
Hc (GPa) 0.60 ± 0.14 0.56± 0.15 0.61 ± 0.14 0.57 ± 0.15 
     
Ht (GPa) 0.56 ± 0.12 0.59± 0.14 0.61 ± 0.13 0.56 ± 0.16 
     
ηc (GPa S) 30370 ± 10555
 b







     
ηt (GPa S) 27870 ± 8111
 b
 36109 ± 11109 
a
 34333 ±11330 30250 ±11049 
     
µc (cm
-1
) 0.029 ± 0.0019 0.030 ± 0.0009 0.031 ± 0.0013 0.032 ± 0.0009 
     
µt (cm
-1
) 0.0206 ± 0.0009 0.0222 ± 0.005
 a
 0.0212 ± 0.0008 0.0220 ± 0.0004 
     
 
Ec = cortical elastic modulus, Et = trabecular elastic modulus, Hc = cortical hardness, Ht = 
trabecular hardness, ηc = cortical viscosity, ηt  = trabecular viscosity, µc = cortical mean 
linear attenuation coefficient, µt = trabecular mean linear attenuation coefficient. LF = 
Left Femur, RF = Right Femur. 
a
 Significant difference from SHAM  (Operated LF) (p<0.05)
 
b
 Significant difference from SCL (Operated LF) (p<0.05) 
c
 Significant difference from SHAM (Intact RF) (p<0.05) 
d
 Significant difference form SCL (Intact RF) (p<0.05) 
Statistical Test: One way ANOVA with Bonferroni corrections (SPSS v.16)   
 
 
However, a significant increase in η was observed in SCL group in both 
cortical (+26.32%, p <0.001) and trabecular bones (+29.56%, p=0.032) as 
compared to SHAM group (Fig. 14A and B). The creep data from SCL and 
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SHAM bones fitted well with Voigt model with all indentations having R
2 
>0.99. 
Figure 14: (A) Cortical and (B) Trabecular viscosity of SHAM and SCL with * 
indicating significant difference between groups, (C) Correlation between η and E 
and (D) Correlation between η and H  
 
Significant positive Pearson‟s correlations between η vs. E and η vs. H 
were observed and the corresponding correlation coefficients were found to be 
0.576 (p=0.002) and 0.528 (p=0.005) respectively. The corresponding linear 
slopes of correlation (m) were of high values, with m=2432 s and m=46795 s 
respectively (Fig 14 C, D). This suggested that when viscosity values increased 
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with sclerosis development in both cortical and trabecular bones, indentation 
modulus (E) and hardness values (H) also increased, but to a much smaller extent.  
 
Tissue level viscoelastic properties 
As observed from Fig. 15, no significant changes in tan delta or damping 
were found across different frequencies from 1-20Hz. Nonetheless, there was an 
observed sharper decline in tan delta at 15.85 Hz for SCL bone than for SHAM 
bone. 
 
Figure 15: Tan delta of SHAM and SCL groups across different frequencies (1-20 
Hz). 
Similarly for storage modulus, no significant differences were found 






















Figure 16: Storage moduli of SHAM and SCL groups across different frequencies 
(1-20 Hz) 
Since E and H did not change at the nano-level and sclerosis effect 
appeared to be localized, there was less likelihood for cortical bone storage 
modulus at the tissue level to be affected. Furthermore, since tan delta, a ratio of 
storage modulus and loss modulus did not vary, it was also within expectation that 




















Figure 17: Loss moduli for SHAM and SCL across different frequencies (1-20 Hz) 
Nonetheless, it could be observed that the decrease in tan delta at 15.85Hz 






























3.5  Discussions 
There is a lack of knowledge in the mechanical property changes 
associated with sclerotic development since earlier models of osteolytic bone 
metastasis did not involve sclerosis (Neudert et al 2003, Bauerle et al 2005, 
Arrington et al 2006, Song et al 2008).  In this study, a sclerotic bone response in 
an immunocompetent animal model was characterized using its 
histomorphometric, densitometric, microarchitectural, as well as elastic and 
viscoelastic property changes. The trends of changes across these different 
properties are summarized in Table 4, where it showed significant increases in 
BMD, BMC, enhanced trabecular microarchitecture (increased BV/TV, BS/TV 
and Tb.N, with reduced Tb.Sp and SMI) and mean attenuation coefficient as well 



























ηc ↑ ↔ ↔ 
ηt ↑ ↔ ↔ 
Ec ↔ ↔ ↔ 
Et ↔ ↔ ↔ 
Hc ↔ ↔ ↔ 
Ht ↔ ↔ ↔ 
BMD ↑ ↔ ↔ 
BMC ↑ ↔ ↔  
Trab.BMD ↔ ↔ ↔ 
BV/TV ↑ ↔ ↔ 
BS/TV ↑ ↔ ↔ 
Tb.N ↑ ↔ ↔ 
Tb.Th ↔ ↔ ↔ 
Tb.Sp ↓ ↔ ↔ 
SMI ↓ ↔ ↔ 
D.A ↔ ↔ ↔ 
µc ↔ ↔ ↔ 
µt ↑ ↔ ↔ 
 
ηc = cortical viscosity, ηt = trabecular viscosity, Ec = cortical elastic modulus, Et = 
trabecular elastic modulus, Hc = cortical hardness, Ht = trabecular hardness, BMD 
=bone mineral density, BMC = bone mineral content, Trab.BMD= trabecular 
bone mineral density, BV/TV= bone volume fraction, BS/TV= bone surface 
density, Tb.N= trabecular number, Tb.Th= trabecular thickness, Tb.Sp = 
trabecular separation, SMI = structural model index, D.A= degree of anistrophy, 
µc = cortical mean linear attenuation coefficient, µt = trabecular mean linear 
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attenuation coefficient. Arrows indicate significant changes with respect to 
SHAM (Operated LF).  
 
As seen from histological results (Fig. 10), sclerotic responses have been 
stimulated as a form of healing flare in this model, with a cascade of osteoblast 
activities. Jaganjac et al (2008) has reported prominent inflammatory response 
and regression of W256 carcinoma in the muscle as a consequence of 
granulocytes response, from day 1 to 6 post-innoculation. Thus, the 10 days 
histological assessment of increased osteoblast activities observed in our study 
could have been brought about as an inflammatory response to the presence of 
W256 cells. Given that this is a preliminary study to investigate the sclerotic 
development, further investigation is required to demonstrate the role of immune 
system in sclerosis development. Nonetheless, it is logical that the presence of an 
intact immune system in bone metastasis animal model is relevant not only for the 
selective growth of tumor types but also for the regulation of bone modeling 
during diseased state.  
 
Increase in new bone formation in the trabecular region  
Micro-CT provides the advantage of non-invasive assessment of bone 
morphology and microstructure, with an established high correlation with 
traditional histomorphometric analysis (Barbier et al 1999). Histological 
observation of enhanced osteoblast activity in sclerotic bone concurred with 
micro-CT indices, indicating enhanced trabecular microstructure. Furthermore, 
micro-CT also provides additional topological parameters such as structural 
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model index (SMI), which is a representative scale between 0 (for ideal plate) and 
3 (for ideal rod) (Lespessailles et al 2006). SMI was shown to have decreased 
significantly in SCL compared to SHAM. This suggests a shift towards more 
plate-like structures of trabeculae in distal metaphyseal area and a plausible 
alteration in mechanical stress distribution in SCL group. Relative magnitudes 
and locations of high principal strains and stresses could differ from that of 
SHAM group, to the possible extent of enhancing load bearing. pQCT parameters 
(BMC, BMD) indicated an overall increase in bone mass and since no significant 
difference in total bone area were found between SCL and SHAM, bone modeling 
mainly affected trabecular microarchitecture and bone mass.  
 
Viscoelastic nano-mechanical properties as a sensitive indicator of bone 
modeling 
SCL bones showed reduced creep effect with significantly increased 
cortical and trabecular viscosity as compared to SHAM. The increased cascade of 
osteoblast activities as observed from histological results could also possibly 
speed up the process of secondary mineralization, with „spill-over‟ to cortical 
areas. Accordingly, the average linear attenuation coefficient per pixel (measured 
by micro-CT) in SCL bone was higher than SHAM bone and was significantly 
increased for trabecular bone. Linear attenuation coefficient can be considered 
proportional to local degree of mineralization (Cox et al 2012, Shahnazari et al 
2010). A higher linear attenuation coefficient per pixel could correspond to 
increased mineralization, contributing to changes in local creep response of SCL 
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bone. It was less likely that collagen organization could have affected the creep 
response, since no abnormalities in collagen fibers or organization was observed.  
This trend of a reduced nano-level creep response with an increased 
mineralization could positively correspond to an earlier work demonstrating a 
similar trend in macroscale viscoelastic behavior of compact bone due to changes 
in mineralization levels (Currey 1975, Les et al 2004). This indicates that changes 
in mineralization levels could have an inverse effect on viscoelastic behavior 
across different scales.   
The positive correlations established between η versus E and η versus H 
are in accordance with an earlier study on canine osteonal tissue (Kim et al 2010), 
although the correlation strength (R=0.576 and 0.528 respectively) in our study 
was not stronger. This could be due to factors such as the presence of cement lines 
and the difference in orientation of collagen fibers that contribute to greater 
degree of heterogeneity.  Since rodent femur microstructures typically do not 
contain secondary osteons (Martiniakova et al 2006), a direct comparison with the 
canine study is not feasible. It is also worth noting that the slopes of correlation 
between η versus E and η versus H were high (m=2432s and m=46795 s 
respectively), indicating that both viscoelastic and elastic parameters have not 
increased together to the same extent. For a smaller increase in E and H, η 
exhibited a greater increase. Accordingly, at the time point of our study both the 
cortical and trabecular E and H did not exhibit a significant difference between 
SCL and SHAM. However, as seen from the correlation study, it is possible that 
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there could be a significant change in E and H with further increases in η at a later 
time point than our study. Nonetheless, viscoelastic nanomechanical property (η) 
changes were found to be a more sensitive indicator of bone modeling than elastic 
nanomechanical properties (E, H).  
 
Tissue viscoelastic behavior 
The sclerosis effect appeared to affect a localized level (nano-level 
viscosity) rather than tissue level as shown in DMA analysis. However, there was 
a sharp decrease in tan δ and loss modulus at 15.85 Hz in SCL compared to 
SHAM group.  Since energy dissipation mechanisms activated at higher 
frequencies (e.g. 15.85 Hz)  are associated with ultra and molecular structures 
(Yeni et al 2007), there might be minor changes at these scales (e.g. mineralized 
collagen fibril) in the cortical bone that have reduced damping efficiency. 
Reduced tan δ was also found in sclerotic bone samples with osteoarthritis (Fortis 
et al 2004), which is in agreement with the noted trend observed from this study.   
Implications for bone material behavior 
Reduced creep response at the tissue level and the indicative changes in 
the microarchitecture of trabecular bone may bear implications for microcrack 
propagation and altered mechanical load distribution respectively in sclerotic 
bone. Viscoelastic behavior (e.g. collagen deformation) helps to dissipate local 
high stresses around microcracks and provide fracture resistance (Ritchie et al 
2009). The material characteristic to undergo limited deformation contributes to 
bone toughness (Ritchie 2011). Thus, reduced creep response in the sclerotic bone 
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tissue would correspond to more microcrack propagation, thereby implying 
reduced bone toughness during cyclic loading (Ritchie et al 2009, Chang et al 
2011). The viscoelastic parameters measured by macroscopic torsion test and that 
of nanoindentation were found to have weak or no correlation, because the 
macroscopic viscoelastic behavior depends on other factors such as fluid flow and 
hierarchical structure of bone bone (Ritchie et al 2009, Shepherd et al 2011). 
Therefore, it is uncertain if the decrease in nanolevel viscoelastic creep property 
associated with sclerotic response in our study would correspond to overall bone 
viscoelastic characteristics. Moreover, despite the decrease in tan δ and loss 
modulus at 15.85Hz, no significant change was established in tan δ or damping 
property at the cortical tissue level. Since sclerosis is a localized development in 
this study, it is still within expectation that there might not be drastic changes at 
the bone tissue level.  
Overall, it is worth noting that sclerosis induces likely changes in load 
distribution and a reduction in intrinsic damping property that could be related to 
changes in overall bone mechanical behavior. Since significant positive 
correlations between elastic properties (E) and (H) with viscosity () were also 
found, we can conclude that mechanical behavior of sclerotic bone would shift 
towards a material with lowered damping and likely with increased stiffness.    
 
Study limitations 
The drying of samples during nanoindentation could affect both elastic 
and viscoelastic mechanical properties that could be attributed to fibril shrinkage 
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(Rho & Pharr 1999). For instance, E and H were found to be higher in dry 
specimens than wet specimens (Bushby et al 2004, Wolfram et al 2010) and state 
of hydration could be important for determining treatment differences in E, H and 
dissipated energy between groups (Ammann et al 2007). As such, the bone 
samples were kept hydrated as much as possible during the sample preparation. 
To reduce the effect of drying during indentation, experimental time for each 
sample was kept constant. In DMA, the bone sample is kept hydrated in a PBS 
bath during testing procedure.  
The effect of embedding could possibly increase E (Bushby et al 2004) 
and H (Mittra et al 2006, Ferguson 2009). Since embedding is needed as 
mechanical support for cutting rodent bones and surface polishing, to minimize 
any interference, indentations on the bone were placed away from epoxy-bone 
interface (Wolfram et al 2010). The time duration from embedding to completion 
of testing was also kept consistent between samples. 
One important limitation of the study is the relatively smaller sample size 
(n=5) for the sclerotic group. Given that this is only a preliminary study, more 
experiments are required to further confirm the involvement of the immune 
system in the development of sclerosis in tumor metastasis. Another limitation is 
the duration of the study that accounts for the earlier changes in bone quality 
induced by tumor metastasis and did not take into account the possibility of 
modeling over longer time period. The ultimate strength and yield of sclerotic 
bones were not measured in this study as well, due to the limited samples.  
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Nonetheless, this is a novel study that centred on possible mechanical and 
material property changes associated with sclerosis that requires further 
exploration for clear understanding. Since sclerosis development is common in 
clinical cases of benign and slow-growing lesions, as correborated by this model, 




In this study, sclerotic response was found to be reactive new bone 
formation and mineralization as a healing flare likely in response to presence of 
W256 carcinoma cells. Here, the immune system is postulated to be responsible 
for the evocation of varying bone responses similar to the clinical scenario.  
Microstructural and densitometric changes showed increased bone formation and 
enhanced trabecular microarchitecture. Significantly reduced creep effect was 
observed in both trabeculae and cortical bone, whereas nanolevel elastic 
properties did not show a significant difference. Therefore, we conclude that 
viscoelastic nanomechanical property would serve as a more sensitive indicator of 
modeling in bone than elastic properties. Reduced viscoelasticity may contribute 
towards microcrack propagation and therefore a reduced toughness. Since 
significant positive correlations between elastic properties (E) and (H) with 
viscosity () were also found, it can be postulated that sclerotic response would 











Chapter 4: Mechanical property changes of 












4.1 Summary of Chapter 
Metastatic cancer cells were found to exert inhibitive effects in vitro on 
osteoblastic cells in terms of proliferation, differentiation and morphology. 
However, there is no prior study on changes of mechanical properties of bone 
cells affected by tumor cells, which could reflect cellular physiological state and 
affect the role of bone cells in mechanosensing and osteogenic response. 
Moreover, earlier in-vitro studies have involved the use of immortalized cell lines 
that may exhibit altered cellular characteristics.  
In this chapter, atomic force microscopy (AFM) indentations on primary 
bone cells exposed to 50% conditioned medium from Walker 256 carcinoma cell 
line (W) or primary tumor (T) (derived from W256 tumor in SD rat) were carried 
out. Bone cell elastic moduli in W and T-groups were found to decrease 
significantly by 61% and 69.6%, respectively compared to control and 
corresponded to f-actin changes. It could also be associated with the variation in 
bone cell differentiation. There was also a significantly higher inhibition of 
growth rate (%) and higher inhibition of alkaline phosphatase activity (%) at 7 
days exposure in T group compared to W group. Inhibition of bone nodule 
formation and mineralization was more apparent in T group than W group.  
This is the first study to demonstrate that there was a significant reduction 
in stiffness of bone cells exposed to tumor conditioned medium, which could in 
turn affect its mechanosensing properties. It also demonstrated that there was a 
stronger sustained inhibitive effect on bone cells viability and differentiation by 
adaptive tumor cells than of its cell line was demonstrated. This could be 
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attributed to the higher levels of TGF-β1 in the T-conditioned medium compared 
to W-conditioned medium.  
 
4.2  Introduction 
In osteolytic metastasis, osteoblast cells affected by tumor cells have a role in 
enhancing osteoclast resorption through the release of receptor activator of nuclear factor-
κB ligand (RANKL) and reduction in osteoprotegrin (OPG) expression (Kozlow & Guise 
2005). Evoked inflammatory cytokines responses (IL-6, IL-8 and MCP-1) by osteoblasts 
cells can promote osteoclast differentiation and activation (Kinder et al 2008).  However, 
further evidence from in-vitro studies suggests that there are more prominant effects on 
osteoblasts due to metastatic cancer cells. This may further explain the in-vivo decrease in 
osteoblast number and bone formation (Phadke et al 2006) as well as lack of healing 
reported even after bisphosphonate treatment (Sasaki et al 1995). 
Osteoblastic cells were found to exhibit increase in apoptosis (Mastro et al 
2004), reduced differentiation in terms of alkaline phosphatase activity, 
osteocalcein, bone sialoprotein and mineralization (Mercer et al 2004, Zhu et al 
2009) after exposure to tumor cell conditioned medium.  Morphological changes 
in osteoblastic cells from cuboidal to elongated spindle-like morphology were 
observed (Zhu et al 2009) with punctuated f-actin fibers (Mercer et al 2004, 
Mercer & Mastro 2005) and reduction in focal adhesion plaques (Mercer & 
Mastro 2005).  
However, there was no report on the mechanical property changes of 
tumor affected bone cells, which could be present given the cytoskeletal changes. 
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Changes in bone cell mechanical properties could impact its mechanosensing 
(Bacabac et al 2008) and also be used to reflect physiological state of cells (Zhou 
et al 2012, Sugawara et al 2008). Atomic force microscopy (AFM) being a 
sensitive force sensor with piconewton resolution could be used to probe and 
quantify cell elasticity (Lim et al 2006).  
Furthermore, earlier in-vitro studies are mainly done on osteoblast-like (MC3T3-
E1) cells or with established breast cancer cell lines (MDA-MB-231 and MCF-7), which 
could possibly exhibit altered phenotype characteristics from the originating tumor with 
continuous culture (Burdall et al 2003). Therefore, this chapter aimed to investigate the 
inhibitive effects of primary tumor culture (derived from Walker 256 inoculated tumor in 
SD rodent) and original cell line used (Walker 256) on primary SD rodent bone cells 
culture.    
Differences in terms of mechanical properties of bone cells exposed to tumor 
conditioned medium as compared to control medium were quantified using AFM 
indentation. Proliferation, differentiation (alkaline phosphatase activity), mineralization 
and morphology of bone cells with exposure to primary tumor conditioned (T) medium or 
W256 (W) conditioned medium were also determined.  
The aims of this chapter were to determine whether:  (1) tumor 
conditioned medium adversely affected the mechanical properties of bone cells, 
(2) there were differences between the inhibitory effects of adaptive tumor cells  





4.3  Methodology 
Primary tumor and bone explant culture 
Tumor inoculation of 10
7
 W256 cells in 0.1 ml M199 culture medium into 
the medullary cavity of left femur was performed, while the right femur was kept 
intact (n=30) (Chen et al 2013a). Three remaining rats were kept intact for bone 
cell harvesting.  In the tumor group, there was invasive soft tissue tumor 
formation, from which tumor tissue was excised at 50
th
 day. 
Tumor tissue was sliced into smaller pieces under sterile conditions and 
placed in 6 well plates with incubation using M199 medium and 5 % horse serum.  
The plates were left undisturbed, with minimal changes of medium during initial 
phases of growth (Masters 2012). 
Soft tissues were thoroughly removed from the harvested bones (n=3 rats) 
and bones were sectioned into smaller pieces. Bone pieces were washed with PBS 
with 2 x antibiotics before being added to 6 well plates and incubated with 
osteogenic medium consisting of DMEM (Invitrogen), 10% fetal bovine serum 
(FBS), 1 x antibiotic-antimyosin and 100µM L-ascorbate (A4403, Sigma). The 
bone explants were maintained undisturbed for 3-4 weeks, until confluency of 
bone cells was achieved (Fig.18). Following which, the bone cells could be 
trysinized and utilized for experimental use.   
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Figure 18: Confluent bone cell culture at 4x magnification under bright-field 
imaging. 
 
Conditioned medium preparation and conditioned treatment of bone cells 
W256 cells (W) and the primary tumor culture cells (T) were individually 
cultured in M199 with 5% Horse serum and replaced with DMEM (5 ml in T-25 
flask, for cell concentration of 2.0 x 10
6
 cells/ml) for 24 hours. W and T-
conditioned medium were collected, with supernatant stored in aliquots at -20
0
C. 
10% FBS and 100µM L-ascorbate were added to the treatment medium prior to 
treatment of bone cells. Bone cells were treated with 50% of either W or T-
conditioned medium and no treatment for control cells (100% osteogenic 
medium).  
W and T-conditioned mediums (without FBS) were assayed for TGF-β1 
production. Culture medium at 3
rd
 day of culture from respective T-conditioned 
and W-conditioned wells were also collected and centrifuged for supernatant. 




according to instructions in Rat TGF-β1 Quantikine ELISA kit (R&D Systems, 
USA) (n=3). Osteogenic culture medium was similarly treated and measured as 
control.  
 
Growth inhibition assay 
2.0 x 10
3
 cells/well were seeded into 96 well plates and after addition of 
conditioned or control medium, cells were left to culture for 3, 5 and 7 days. 10 µl 
of MTT (5mg/ml in PBS) was added to each well and after 4 hours, the medium 
was removed and 100 µl of DMSO added. Absorbance values at 595nm were read 
on the microplate reader. Growth Inhibition rates (%) were calculated as follows 
in Equation 10 (Chen et al 2013b):  
   
                                        
                                         
       
 
Alkaline phosphatase (ALP) activity 
2.0 x 10
4
 cells/well were seeded onto 24-well plates and with addition of 
conditioned or control medium, cells were left to culture for 3, 5 and 7 days. ALP 
activity was monitored with incubation of bone cells with 200µl pNPP liquid 
substrate (P7998, Sigma Aldrich) for 30 mins, with 50 µl of 3 N NaOH solution 
added to stop the reaction.  Absorbance measurements at 405nm were made using 






Von Kossa Assay 
  2.0 x 10
4
 cells/well were seeded onto 24-well plates and after exposure of 
conditioned or control medium for 7 days, the medium was replaced with fresh 
osteogenic medium with addition of 10 mM sodium-glycerophosphate (Sigma 
Aldrich, USA) for 2 weeks. The cells were then washed with PBS and stained 
with 1% Silver Nitrate (Sigma) under UV exposure for 40 mins. The cells were 
then washed with distilled water and 3% sodium thiosulphate was added for 5 
mins, before being removed and washed with distilled water.  Images were 





 cells/well were grown for 3 days with conditioned medium or 
control medium in a 24-well plate.  The cells were fixed using 4% 
paraformaldehyde (Sigma Aldrich, St. Louis, USA), followed by labeling with 
0.1µg/ml TRITC-Phalloidin (Sigma Aldrich, St. Louis, USA) for f-actin and 
5µg/ml DAPI (Sigma Aldrich, St. Louis, USA) for cell nucleus.  Fluorescence 
imaging was then conducted using Olympus FV1000 confocal imaging system. 
Cell morphology analysis (N = 7 cells per group) was conducted using Image J 
software (NIH, MD, USA) by determining projected cell area and aspect ratio i.e. 






Atomic Force Microscopy 
1.0 x 10
4
 cells were seeded on sterile 13 mm glass cover slips (Heinz glass) 
and after growing for three days, the live cells were subjected to AFM indentation 
using nanoscope IV multimode AFM with a picoforce scanner (Digital 
Instruments Inc, USA) The cells were kept immersed in phosphate buffered saline 







Figure 19: AFM fluid cell set-up where cells can remain hydrated in phosphate 
buffered saline under experiment loading conditions  
 
For measuring cell mechanical property (n=30 cells per group), a silicon 
nitride cantilever of spring constant 0.03 N/m with a spherical polystyrene bead of 
diameter 4.5 µm adhered to the tip (NovaScan technologies) was used for 
indentation at 200pN, 0.1 Hz (Muthukumaran et al 2012). The indentation was 
done at the centre of cell, to minimize influence of the substrate.  The apparent 
elastic modulus (E) of the sample can be determined from the force (F) versus 
indentation depth (h) curve. Hysteresis was calculated by subtraction of area 
under curve for retraction from approach curve, which gave energy dissipated into 
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the cell from AFM tip indentation (Lieber et al 2003) and also provided an 
indirect measurement of the apparent viscosity of the sample (Rebelo et al 2013).  
Deflections in the AFM tip arising from interactions with the sample 
placed on a piezoelectric platform are detected through changes in position of 
reflected laser beam on the 4-point photodetector system. Force (F) versus 
displacement (Z) curves (Fig. 20) can be obtained from AFM force mode, where 
force is calculated using Hooke‟s law, F = K*d, where K is elastic spring constant 
and d is deflection of cantilever.  Before coming into contact with the sample, 
force remains at zero value. As the sample is shifted up towards the fixed AFM 
tip i.e. Z increases, there comes a point at which the AFM tip comes into contact 
with the sample. Beyond the contact point, Z continues to increase, but there 
would be deflection of the cantilever (reflected as increase in force values in the 
approaching curve) and indentation into the cell sample. Once the trigger force is 
reached (pre-determined by user), the sample is retracted downwards i.e. Z 
decreases. A non-zero force Fadh (adhesion force) may be required to remove the 
tip from the sample.  At point of contact, Z = 0 and penetration depth into the cell 
(h) is given by h = Z- d. Determination of point of contact is critical for deriving 
values of h and therefore E, stiffness values for cell, as shown in subsequent 








Figure 20: Force-displacement curves obtained from AFM elastic tests.  
From Hertz-Sneddon model, the force can be related to the indentation as 
in equation (11):  
 
where R is the radius of the spherical bead (2.25 µm) on the indent tip, ν is the 
Poisson‟s ratio, assumed to be 0.5 for biological samples (Darling et al 2008). Ecell 
is Elastic modulus of cell and h is indentation depth into cell. Fig 21 illustrates 
indentation into the cell using an AFM probe.   




Figure 21: Spherical AFM tip on adhered cell (Bacabac et al 2008).  
 
Statistical Analysis 
SPSS 16.0 software was used to conduct one-way ANOVA analysis 
among different group comparisons, with p <0.05 used for significance. Results 
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were shown as mean ± SD and for AFM experiments, results were represented as 
mean ± SEM (Standard Error of Mean). For equal variances, Tukey‟s HSD post 
hoc test was used for comparisons between 6 groups. For non-equal variances, 
Tamhane‟s post hoc test was used. Bivariate linear Pearson‟s correlation 
coefficients were also established with p<0.05 (2 tailed) for significance. 
 
4.4 Results  
Radiography and histological analyses 
W256 carcinoma cells were injected in the medullary approximately 5mm from 
the distal growth plate of the left femur (Fig. 22A).  Radiograph of the distal left 
femur showed a large soft tissue mass, with parts of bone cortex having eroded at 
distal growth plate (Figure 22B). Elevated periosteal reaction at the proximal 
margin of tumor or „Codman‟s triangle‟ (Bullough 2012) was also observed.  In 
histological results, growth and expansion of the tumor cells into the soft tissue 
surrounding the bone and degradation of bone tissue at the distal growth plate was 
observed (Fig. 22D) as compared to sham operated bone (Fig. 22C), concurring 
with radiographical results. It demonstrated the osteolytic effect of the injected 










Figure 22: (A) Immunocompetent SD rat injected with W256 carcinoma cells, (B) 
aggressive malignant lesion (white arrow) induced with elevated periosteal 
reaction and a soft tissue mass with aneurysmal features (C) histological image of 
sham operated bone and (D) of tumor (T) burdened bone at same magnification. 
 
TGF-β1 production 
TGF-β1 in acid-activated T- and W-conditioned medium (without FBS) 
were found respectively, to be 20.2 pg/ml and 14.3 pg/ml. Acid activated medium 
collected at 3
rd
 day of culture from T- and W-conditioned wells showed that TGF-
β1 levels were 113.3 pg/ml and 65.9 pg/ml respectively, after correction for basal 
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medium TGF-β1 levels. It appeared that there was a dose-dependent effect on 
TGF-β1 production by bone cells through exogenous TGF-β1 conditioning, which 
agreed with an earlier report (Dallas et al 1994).    
 
Growth inhibition rates 
As observed from Fig 23A, T-conditioned medium had a twofold higher 
inhibition of bone cells growth than that of W conditioned medium at 3 days of 
exposure (+12.93%, p<0.001) and at 7 days of exposure (+13.34%, p=0.008). 
There was no significant difference in inhibition rates for T group from 3 to 7 
days. By two way ANOVA analysis, only the treatment medium was indicated to 
have significant effect (p<0.001). 
 
 
Figure 23: (A) Growth inhibition of bone cells and (B) Alkaline phosphatase 
activity inhibition of bone cells by W and T conditioned medium for 3, 5 and 7 
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days of exposure. * indicated p <0.05 and ** indicated p <0.001 for one way 
ANOVA analysis, with Tukey‟s HSD post hoc test.  
Alkaline phosphatase (ALP) activity inhibition 
T group had a significantly higher inhibition of ALP activity than W group 
at 7 days exposure (+13.57%, p =0.016). While there was no change in inhibition 
rate of ALP activity by T conditioned medium, there was decreasing inhibition by 
W conditioned medium on ALP activity from 3 to 7 days (Fig. 23B). W group 
inhibition rate at 7
th
 day was significantly lower than that on 3
rd
 day (-15.12%, 
p=0.008).  The two main effects, number of days of exposure (p=0.002) and the 
treatment medium (p =0.002) was each indicated to be significant by two-way 
ANOVA analysis.  
Mineralization 
T conditioned bone cells after 7 days exposure (Fig. 24C) did not form 
brown stained mineralized nodules, as compared to the control bone cells (Fig. 
24A). The degree of mineralization was reduced, as seen from the lower presence 
of brownish stains. The size of nodule formed was smaller for bone cells exposed 





Figure 24:(A) Von Kossa staining of Control well, (B) W conditioned well (C) T 
conditioned well at 4x magnification; corresponding F-actin staining of (D) 
control well, (E) W-conditioned well and (F) T-conditioned well at 40x 
magnification, scale bar: 50m.  Cell nucleus was counterstained with DAPI.    
Morphological changes 
Control bone cells retained their cuboidal morphology with dense actin 
fibers (Fig.24D), with mean cell area 2322 ± 1362 µm
2 
and aspect ratio 1.68 ± 
0.46. Exposure to W and T conditioned medium for 3 days induced morphology 
changes, with reduced cell area (1158 ± 481 and 1004 ± 614 µm
2
 respectively for 
W and T groups) and significant elongation i.e. higher aspect ratio 3.55 ± 1.67 (p 
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=0.046) and 2.71 ± 0.917 (p =0.0.36) respectively for W- (Fig. 24E) and T- 
conditioned groups (Fig. 24F).  
Density of f-actin fibers was observed to be reduced across centre of cell 
in W-conditioned group and punctuated stress fibers of bone cells in T-
conditioned group were noted. F-actin fluorescence levels across groups were 
quantified using micro-plate reader (data not shown) and no significant 
differences were observed. Thus, changes of cytoskeleton occurred in the 
reorganization of f-actin fibers and not as a reduction of f-actin expression levels.   
 
Elastic modulus and hysteresis values of bone cells  
It was observed that there were higher indentation depths for the same 
indentation load for both W- and T-conditioned groups compared to control 
(Figure 25A). For the same given loading force, the indentation depth will be 
larger given that the resistance against the mechanical load is reduced for both W 
and T group bone cells. Correspondingly, E was shown to have decreased 
significantly for W- and T- conditioned groups by 61.0% (p <0.001) and 69.6% 
(p<0.001) respectively, compared to control (Figure 25B). Hysteresis values or 
energy dissipated during indentation were shown to have increased by 152.9% 
(p= 0.027) and 161.3% (p=0.001) for W- and T- conditioned groups respectively, 
compared to control (Figure 25C). There was also a significant negative Pearson‟s 





Figure 25: (A) Graph of indentation force versus depth, (B) Bar plot of elastic 
moduli and (C) Bar plot of hysteresis values for control, W conditioned and T 
conditioned groups. **-indicated p<0.001, * -indicated p <0.05. 
 
4.5 Discussions 
In this first study to look into mechanical property changes of bone cells 
conditioned by tumor cells, there was also an emphasis on the comparison of 
effects of primary tumor cells with original cell line.  It is well understood that the 
selective adaptation of tumor cells and osteolysis development depended on 
inherent tumor characteristics to form symbiotic interactions with host cells in the 
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bone microenvironment (Fidler 2003). Moreover, new variants of tumor could 
result from differential propagation of tumor subpopulations in a process 
involving the immune system (Khong & Restifo 2002). As such, it is postulated 
that a primary tumor cell culture established from an in-vivo model of tumor 
burden, could have selectively different characteristics from that of the 
immortalized tumor line. Therefore, it would be pertinent to examine any possible 
contrasts in effects for primary tumor conditioned medium on bone cells, since 
earlier in-vitro studies have used tumor cell line conditioned medium.  
Overall, it was demonstrated that there was a stronger and sustained 
inhibitive effect on bone cells viability, differentiation i.e. alkaline phosphatase 
activity as well as mineralization by primary tumor conditioning compared to 
W256 conditioning. This could be directly attributed to the higher levels of TGF-
β1 in the T-conditioned medium compared to the W-conditioned medium. An 
earlier study has corroborated with this observation, demonstrating that the 
presence of TGF in the conditioned medium of MDA-MB-231 was in part, 
responsible for the inhibition of osteoblast differentiation (Mercer et al 2004).  
TGF- β has been shown to play both positive and negative influences over 
osteogenic differentiation (Li et al 2012a, Zhou 2011, Zhao et al, 2010) and cell 
viability (Li et al 2012a, Dufour et al 2008) and its effects vary based on 
concentration and cell types (Li et al 2012a, Ochiai et al 2012, Zhou 2011). 
Nonetheless, it has been shown that repeated exposure to low dosage of TGF-β1 
could reduce IGF-1 expression and down regulation of PI3K/Akt pathway, 
resulting in the inhibition of osteoblast differentiation (Ochiai et al 2011). As such, 
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the concentration differences of growth factors in different conditioned mediums 
could contribute to the varied inhibitive effects on bone cells.  
It was further shown in this study that there was significantly reduced 
elasticity and increased energy dissipation of the bone cells exposed to the tumor-
conditioned medium. This suggested the potential of cell mechanical property 
changes as an indicator of physiological health of bone cells. The actin network is 
demonstrated to be important for cell mechanical stability and directly affects cell 
elastic modulus (Rotsch & Radmacher 2000, Li et al 2008,  Muthukumaran et al 
2012). Thus, the observed reduction in elastic modulus and increased hysteresis 
could be associated with the changes in f-actin organization with tumor 
conditioning; where f-actin density was not only reduced across centre of cell 
(indentation location) but also more punctuated.  
The reduced stiffness could also be linked to variation in degree of cell 
differentiation, since alkaline phosphatase activity (an early differentiation marker) 
was inhibited in both types of tumor conditioned medium. Darling et al showed 
that there were distinct mechanical property differences between different 
phenotypes of differentiated cells and of undifferentiated bone marrow derived 
mesenchymal stem cells (Darling et al 2008). Thus, inhibition of differentiation 
by tumor conditioning could result in variation of stages of bone cell phenotypes 
from control, with differing mechanical properties and morphology.   
There could be another contributing factor to the altered cell stiffness i.e. 
the substrate, since actin network rearranges on attachment to extracellular matrix 
(Takai et al 2005). With 7 days exposure to W and T conditioned medium, there 
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was inhibition in terms of the degree of mineralization and formation of bone 
nodules after 2 weeks. Therefore, it was possible that at the time-point of the 
AFM study (3 days exposure) there could be differences in mineralization that 
could contribute to variation in cell cytoskeletal arrangement and thus stiffness.  
However, quantification of mineralization at 3 days time point did not indicate a 
significant difference in mineralization between the groups. Thus, substrate 
mineralization may not contribute to the observed differences in cell stiffness.  
The ability of bone cells to detect mechanical signals and respond with 
appropriate biochemical signals is dependent on the cytoskeleton (Myers et al 
2007, Li et al 2007). For instance, through microfilament disruption, osteoblasts 
under cyclic compression loading were inhibited in c-Fos mRNA and protein 
expression that is important for bone growth and mineralization (Li et al 2007). 
Changes in bone cell mechanical properties could also impact its mechanosensing 
(Bacabac et al 2008).  Changes in F-actin organization and increased 
deformability of T- and W-conditioned bone cells (lowered stiffness) could 
therefore affect their mechanosensing properties and contribute to changes in 
remodeling events. 
Nonetheless, there were some limitations in this study, namely experiment 
time-point i.e. 3 day tumor conditioning for AFM indentations and experimental 
conditions e.g. temperature and substrate. Since this is only a preliminary study to 
examine mechanical properties of tumor conditioned bone cells, it will be part of 
future work to examine if the reduced bone cell stiffness would be sustained over 
a longer periods of tumor conditioning. Given that cell mechanical properties 
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were demonstrated to have changed significantly, it is also of interest to examine 
whether bone cell mechanosensing properties would be similarly affected in 
future experiments (Chapter 5).   
All AFM indentations were conducted on hydrated glass slips under room 
temperature. Since differences in cell cycle could also contribute to the inherent 
differences in cell mechanical properties (Kelly et al 2011), confluent cells were 
used for AFM assessment, similar to the cell preparation used by Muthukuraman 
et al to control the cell cycle for assessment of cell E across the groups. As 
relative cell attachment could affect cellular mechanical properties, experimental 
durations were controlled to ensure that analyzed cells from all 3 groups remained 
attached during experiment to ensure consistent comparisons.   
The Hertz-Sneddon model used here for quantification of cell stiffness has 
three main assumptions: (1) the rigidity of the probe is much higher than the 
sample, (2) probe penetration is much smaller than radius of probe and (3) there is 
lack of adhesion between probe and sample. Since the probe is typically more 
rigid than the cell sample, radius of sphere (2.5m) is much higher than depth of 
penetration (controlled at 100-300nm) and the adhesion forces were negligible (as 
observed from the retraction curve), this model is still valid for comparisons 








In our study, it was demonstrated that there was stronger sustained 
inhibition of bone cells viability, differentiation, mineralization by primary tumor 
conditioned medium than the original cell line conditioned medium. This could be 
attributed to higher levels of TGF-β1 in the T-conditioned medium than that of 
W-conditioned medium. There was significantly reduced stiffness and increased 
hysteresis of bone cells exposed to tumour conditioned medium, which could be 
associated with the changes in cytoskeleton and possibly differences in 
differentiation. This suggested the potential of cell mechanical property changes 
as an indicator of physiological health of bone cells. Moreover, since changes in 
bone cell mechanical properties could impact its mechanosensing, it will be 
interesting to examine changes in mechanosensing property of bone cells in the 















Chapter 5: Mechanosensing of tumor 












5.1 Summary of the chapter 
It was earlier demonstrated that there were significant reduction in cell stiffness 
and increased hysteresis with tumour conditioned bone cells, associated with cytoskeleton 
changes and possibly cell differentiation stage. Since mechanosensing is mediated by cell 
cytoskeleton, it is postulated that there could be mechanosensing changes in bone cells 
affected by tumour conditioning.   
Primary tumor cells were revealed to have anchorage independence, 
indicating their metatatic potential, as well as a similar phenotypic signature with 
the original W256 cell line. However, size difference in colony formation 
suggested varying tumor subpopulations being propagated, which may explain the 
differences in inhibitive effects on bone cells. Here, T-conditioned bone cells 
were shown to form defective matrix deposition that could reinforce negative 
feedback for differentiation, mechanical characteristics and thus mechanosensing 
of attached bone cells.  Correspondingly, it was demonstrated in this study that 
only T conditioning exerted inhibitive effects on nitric oxide release in response 
to LMHF vibration. It could also be due to the higher levels of TGF-β1 in T-
conditioned medium than that of W-conditioned medium.  
    LY294002, an inhibitor of PI3K signaling pathway through which TGF-
β, IGFII and PDGF mediate their effects on cytoskeleton, was thus used at a 
dosage of 1µM. It was shown to alleviate the inhibition on mechanosensing 
properties of T-conditioned cells, possibly through the maintainence of 
cytoskeletal organization in tumor affected cells.  It suggested that growth factors 
like TGF-β1 could be good pharmocological targets for osteoblast treatment in 
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osteolytic metastasis. The inhibition on mechanosensing by bone cells could thus 
contribute to the defunct bone formation activity.  
 
5.2 Introduction 
Earlier in-vitro experiments have demonstrated that tumor cells exert 
inhibitive effects on osteoblast proliferation (Mastro et al 2004, Zhu et al 2009) 
and differentiation (Zhu et al 2009) as well as affect their morphology (Mercer & 
Mastro 2005, Dhurjati et al 2008, Zhu et al 2009). LY294002, a PI3K/Akt 
inhibitor, has been shown to maintain the morphology of breast cancer 
conditioned bone cells, demonstrating that induced morphology changes were 
mediated through PI3K pathway (Mercer & Mastro 2005).  
In the previous chapter, we further demonstrated that there was a significant 
reduction in stiffness and increased hysteresis of bone cells exposed to primary tumor 
conditioned medium. Bone cell mechanical property changes were found to be associated 
with f-actin structure changes and possibly with differentiation stages. Since 
mechanosensing of bone cells is mediated by the cytoskeleton (Willems et al 2011), it is 
postulated that there would also be inhibition of mechanosensing property with tumor 
conditioning.   
Mechanosensing i.e. sensing of mechanical signals leading to biochemical 
responses (Adachi et al 2008), plays a vital role in bone cells functionality (Kreja et al 
2008, Tanaka et al 2005) and thus, tissue level adaptation to mechanical loading (Li et al 
2007). Osteoblastic cells have been demonstrated to express osteogenesis related factors 
with exposure to low amplitude, high frequency vibrations( Bacabac et al 2006, Patel et al 
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2009, Hou et al 2011, Pre et al 2011).  The anabolic effect of low magnitude, high 
frequency (LMHF) vibration has also been demonstrated in sheep at 0.3g, 30 Hz (Rubin 
et al 2002), mice at 0.3g, 45 Hz (Xie et al 2008) and ovariectomized rats at 3g, 30Hz 
(Rubinacci et al 2008) and 0.3g, 35Hz (Shi et al 2010) . As such, mechanosensing 
changes of tumor conditioned bone cells to LMHF vibrations could be of interest, since it 
helps to elucidate the potential of LMHF vibrations in stimulating osteogenic response in 
tumor affected bone cells. 
  Nitric oxide is important in the signaling of bone cells for the regulation 
of bone remodeling and the addition of an inhibitor of nitric oxide (L-NAME) 
also inhibited mechanically induced bone formation in rodents (Turner et al 1996).  
This provided supporting evidence for the role of nitric oxide in mechanotransduction and 
as an indicator for mechanosensing by bone cells. Thus, monitoring of nitric oxide levels 
in response to LMHF vibrations could be used to reflect changes in mechanosensing and 
degree of bone cell activation to mechanical stimuli.   
The bone matrix deposition of tumor conditioned bone cells i.e. mineralization 
pattern and the physical quality of collagen fiber formation would also be examined. It 
was found in osteoporotic bone matrix that there was increased amount of new collagen 
with increased lysine hydroxylation which contributed to the deterioration in bone quality 
(Knott et al 1995). Collagen synthesis has been shown to be down-regulated for tumor 
affected osteoblast cells (Dhurjati et al 2008), but the characteristics of collagen fibers 
deposited were not examined previously.   Structural organization of collagen fibers and 
mineralization pattern could not only contribute to tissue integrity, but also affect 
mechanical characteristics and thus mechanosensing of attached bone cells.  
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Thus, the aims of our study were to determine whether:  (1) tumor 
conditioned medium adversely affects the mechanosensing properties of bone 
cells to low magnitude high frequency vibration, (2) there were differences in 
bone matrix deposition in terms of collagen fiber organization and degree of 
mineralization for primary tumor cells (T) conditioned cells and that of W256 




Tumor inoculation of 10
7
 W256 cells in 0.1 ml M199 culture medium into 
the medullary cavity of left femur were performed using a 22G needle, while the 
right femur was kept intact (n=30) (Chen et al 2013a).  3 remaining rats were kept 
intact for bone cell harvesting from femur bones.  All animal experiments were 
conducted accordance with an approved protocol from Institutional Animal Care 
and Use Committee (IACUC) at National University of Singapore.  
 
Primary tumor and bone explant culture 
Tumor tissue was sliced into smaller pieces under sterile conditions and 
placed in 6 well plates with incubation using M199 medium and 5 % horse serum. 
The plates were left undisturbed, with minimal changes of medium during initial 
phases of growth (Masters 2012).   
Soft tissues were thoroughly removed from the harvested intact bones 
(n=3 rats) and bones were sectioned into smaller pieces. Bone pieces were washed 
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with PBS with 2 x antibiotics before being added to 6 well plates and incubated 
with osteogenic medium consisting of DMEM (Life Technologies, USA), 10% 
fetal bovine serum (FBS), 1 x antibiotic-antimyosin and 100µM L-ascorbate 
(A4403, (Sigma Aldrich, St. Louis, USA). The bone explants were maintained 
undisturbed for 3-4 weeks, until confluency of bone cells was achieved. 
Following which, the bone cells could be trysinized and utilized for experimental 
use.     
 
Immunostaining for cytokeratin and vimentin expression  
  2.0 x 10
4
 W and T cells were seeded respectively into 24-well plates and 
at least 50% confluency was reached before cells were fixed with absolute 
methanol for 10mins in room temperature. Non-specific binding sites were 
blocked with 1:5 fetal bovine serum in PBS for 20 mins. Incubation with primary 
antibodies i.e. anti-vimentin produced in goat (V4630, Sigma Aldrich, St. Louis, 
USA) at1:100 and anti-pan cytokeratin produced in rabbit (C2562, Sigma Aldrich, 
St. Louis, USA) at 1:100 for 1 hour was then carried out. PBS was used to wash 
the wells for 3 times. Incubation with appropriate secondary antibodies anti-goat 
IgG- TRITC (Sigma Aldrich, St. Louis, USA) and anti mouse IgG-FITC (Sigma 
Aldrich, St. Louis, USA) at 1:100 and 1:32 respectively for 1 hour was carried out. 
PBS was again used to wash the wells and to incubate the wells for fluorescence 





Soft agar assay for colony formation 
Soft agar assay tests for anchorage independent growth in soft agar and is used for 
detecting in-vitro cellular transformation and predicting potential for inducing metastasis 
in-vivo (Li et al 1989). In brief, 0.6% bottom agar is prepared by mixing 1.3ml of 1.8% 
agar with 2ml of 2x M199 and 0.7ml of double distilled water. They were maintained at a 
temperature of 42 
0
C and plated in tissue culture plate to solidify. 0.3% top agar is 
similarly prepared, by mixing equal volume of 0.6% agar with equal volume of cells 
suspension (20,000 cells/ml) at 37 
0
C. The top agar was left to solidify before being 
placed in the incubator.  Soft agar assay was maintained at least for 2 weeks, with topping 
up of medium if agar appeared dry.  
 
Conditioned medium preparation and conditioned treatment of bone cells 
W256 cells (W) and the primary tumor culture cells (T) were individually 
cultured in M199 with 5% Horse serum and replaced with DMEM (5 ml in T-25 
flask, for cell concentration of 2.0 x 10
6
 cells/ml) for 24 hours. W and T-
conditioned medium were collected, with supernatant stored in aliquots at -20
0
C. 
10% FBS and 100µM L-ascorbate were added to the treatment medium prior to 
treatment of bone cells. Bone cells were treated with 50% of either W or T-
conditioned medium and no treatment for control cells (i.e. 100% osteogenic 
medium).   
Type I Collagen staining  
2.0 x 10
4
 bone cells were seeded onto 24-well plates and after exposure to 
conditioned or control medium for 7 days, the medium was replaced with fresh 
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osteogenic medium for 3 weeks. Fixation of cells were first carried out using ice cold 
methanol (-20ºC).  3% of bovine serum albumin (BSA) solution was added to each well 
for 30 mins before being removed.  200 µl of Mouse Anti-collagen I antibodies in 1:1000 
dilution (C2456, Sigma Aldrich) was added to each well and incubated for 90 mins at 
room temperature. Phosphate buffered saline (PBS) was used to rinse the wells for 3 
times. 200 µl of goat anti-mouse antibody in 1:400 dilution (Alexa Fluorophore 594, Life 
Technologies, USA) was added in the dark together with DAPI stain and incubated for 45 
mins at room temperature. Each well was rinsed 3 times with PBS and final amount of 
300 µl of PBS was added to each well for viewing under the fluorescence microscope. 
Image J was used to measure collagen fiber lengths, using a threshold function to identify 
fibers (Chen et al 2012).  
 
Mineralization of extracellular matrix 
  Von Kossa assay is used to assess for in-vitro mineralization. 2.0 x 10
4
 
bone cells were seeded onto 24 well plates and after exposure of conditioned or 
control medium for 7 days, the medium was replaced with fresh osteogenic 
medium with addition of 10 mM sodium-glycerophosphate (Sigma Aldrich, St. 
Louis, USA) for 2 weeks. The cells were then washed with PBS and stained with 
1% Silver Nitrate (Sigma Aldrich, St. Louis, USA) under UV exposure for 40 
mins. The cells were then washed with distilled water and 3% sodium 
thiosulphate was added for 5 mins, before being removed and washed with 
distilled water.  Images were captured using optical inverted microscope 






 cells were seeded into 96-well plate and after addition of 
conditioned medium or normal medium for three days, serum starvation (for 1 
day with DMEM with 2.5% fetal bovine serum) for cell cycle synchronization 
was carried out before being maintained in normal osteogenic medium.  Vibration 
was carried out for 20 mins at room temperature on a vibration platform (Juvent 
1000R, Juvent Inc., USA) which provides vertical accelerations at 0.3g, 30 Hz. 
The non-vibrated well-plate was placed at room temperature for same period. The 
well plates were returned to the incubator at 37
 0 
C for 1 hour before being 
quantified for nitric oxide. The vibration is repeated for another day, with 
experimental outline of cell preparation and other assays shown in Fig.26. 
 
Figure 26: Experimental outline of cell preparation and analysis.  
 
Nitric oxide detection  
 The nitric oxide concentration may be measured indirectly by nitrite and 
nitrate determination, since nitric oxide quickly metabolizes to the more stable 
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compounds of nitrite and nitrate.  Briefly, 100 µl of medium from each well was 
removed and reacted with equal volume of Griess reagent (Sigma Aldrich, USA) 
at room temperature for 10 mins. Measurement of the absorbance at 550 nm was 
carried out and nitrite concentration was determined from a sodium nitrite 
standard curve using 0-100µM of NaNO2. Results were normalized by respective 
controls (non-vibrated cells), with n=6 sets of experiments.  
 
Alkaline phosphatase assay 
ALP levels were monitored by incubating bone cells with 200µl pNPP 
liquid substrate (P7998, Sigma Aldrich, USA) for 30 mins, with 50 µl of 3 N 
NaOH solution added to stop the reaction.  Absorbance measurements at 405nm 
were made using a microplate reader 
 
Cell growth assay (MTT assay) 
10 µl of MTT (5mg/ml in PBS) was added to each well and after 4 hours, 
the medium was removed and 100 µl of DMSO added. Absorbance values at 
595nm were read on the microplate reader. 
 
Effects of LY294002 (PI3K inhibitor) with vibration 
LY294002, a PI3K/Akt inhibitor, has been shown to maintain the 
morphology of breast cancer conditioned bone cells, which implied that induced 
morphology changes were mediated through PI3K pathway (Mercer & Mastro 
2005). To investigate the possible role of PI3K pathway and cell morphology on 
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 cells were seeded into 96-well plate and treatment with or 
without 1µM of LY294002 (Sigma Aldrich, St. Louis, USA) was carried out prior 
to addition of conditioned medium or normal medium. The cells were 
subsequently incubated for three days, followed by serum starvation for cell cycle 
synchronization before being maintained in normal osteogenic medium.  
Vibration was carried out carried out for 20 mins at room temperature with 
vibration platform (Juvent 1000R, Juvent Inc., USA) at 0.3g, 30 Hz and nitric 
oxide levels were quantified 1 hour after one vibration (n=3). Morphological 
changes of cells at the same time point i.e. 1 hour after vibration was imaged 




SPSS 16.0 software was used to conduct one-way ANOVA analysis 
among different group comparisons, with p <0.05 used for significance. For equal 









Vimentin and Cytokeratin expression 
There was intense positive stainings for vimentin in both tumor explants 
cells (T) and W256 (W) cells (Fig. 27), with light or minimal staining for 
cytokeratin expression. Immunophenotypic analysis indicated that both T and W 
cell types are hematopoietic in origin (Simpkins et al 1991), with minimal 
epithelial cell markers.   
 
Figure 27: Vimentin and cytokeratin expression of (T) tumor explants and (W) 
W256 cells, at 60x magnification, scale bar: 30 m 
 
Anchorage independence 
As observed from W256 and primary tumour cells colony formation, 
W256 (W) cells tended to form larger colonies (Fig. 28A) as compared to that of 
that of primary tumor cells (T) with numbers of smaller colonies (Fig. 28C and 
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D). Both W256 cells and primary tumor cultured cells demonstrated anchorage 
independence, which is one of the characteristics for cells with metastatic 
potential (Li et al 1989). 
 
Figure 28: Soft agar assay of W256 cells, with (A) one large colony and (B) 
smaller colonies; (C, D) Tumor cells with smaller colonies at 10x magnification 
after 13 days.  
Type I Collagen formation   
The control bone cells tended to form more distinct fibers (Fig. 29A) than 
W- (Fig. 29B) and T-conditioned bone cells (Fig.29C). For T-conditioned bone 
cells, the type I collagen formed were observed to be more amorphous, without 
any distinctive fiber organization. Lengths of collagen fibers formed (Fig. 29D) in 
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control group (50.4 ± 15.6 µm) were also significantly longer by 69.1% (p=0.002) 
and 98.4% (p<0.001) respectively, compared to W-conditioned (29.8 ± 10.2 µm) 
and T-conditioned groups (25.4 ± 8.95 µm). 
 
Figure 29: (A) Collagen I staining of control cells with distinct collagen fiber 
organization, (B) W conditioned cells with less distinct collagen fiber 
organization, (C) T conditioned cells with amorphous collagen formation at 20x 
magnification at 3 weeks and (D) Bar plot of collagen fiber length, *-indicated p 







Control cells presented larger area of bone nodules and darker stainings of 
mineralization (Fig. 30A, B) than W conditioned cells (Fig. 30C, D) as well as T 
conditioned cells (Fig. 30E, F), which showed smaller area of bone nodules and 
less intense brownish staining. The pattern of mineralization was observed to be 
around the foci of nodules, with some dispersed mineralization present in all 3 
groups.   
 
Figure 30: (A, B) Von Kossa staining of control cells with larger size of bone 
nodules formed and darker staining of mineralization; (C, D) W conditioned cells 
with smaller area of bone nodules and less intense staining and (E, F) T 
Control W-conditioned T-conditioned 
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conditioned cells, less intense stainings of mineralization. All pictures taken at 4x 
magnification at 2 weeks, with n=3 sets of experiments.  
 
Nitric oxide changes  
There was an observed increase in nitric oxide levels in vibrated control 
bone cells in Figure 30. There was significant lower nitric oxide levels (p=0.037) 
in vibrated T conditioned cells on day 1 vibration, suggesting that tumor 
conditioning inhibited bone cell activation and mechanosensing.     
 
Figure 31: Normalized nitric oxide levels across 3 groups (control, W conditioned 
and T conditioned cells) in vibrated plates at 0.3g, 30 Hz. Results are presented in 
mean ± SEM, n=6 sets of experiment. * indicated p<0.05 for one way ANOVA, 




Alkaline phosphastase activity and cell growth  
Fig. 32: Normalized ALP and MTT levels across 3 groups (control, W- and T- 
conditioned cells) in vibrated plates.  Results are presented in mean ± SD, n=3 
sets of experiment. 
As shown in Figure 32, there were no significant changes in bone cell 
differentiation (ALP activity) and growth rates with vibration, with normalized 
ALP and MTT levels equivalent to respective non-vibrated groups at 22 hours 







With LY294002 treatment (PI3K inhibitor)  
 
Figure 33: Bar chart of normalized NO levels in Control, W- and T-conditioned 
groups, with or without LY294002 treatment (PI3K inhibitor).  F-actin staining at 
60x magnification, for control (C), W256(W)- and T-conditioned groups (T) with 
or without treatment of LY294002, with vibration. 
Nitric oxide (NO) response of bone cells to LMHF vibrations were 
significantly inhibited by 78.2% (p =0.013) in untreated T-conditioned cells (Fig. 
33) but not in untreated W-conditioned cells. On the other hand, no significant 
difference was found between LY294002 treated T-conditioned cell from both 
control groups (untreated and treated with LY294002), indicating that NO 
response with treatment is similar to that of control.  
With vibration, LY294002 treated W-conditioned cells (Fig. 33) were 
morphologically similar to that of both treated and untreated control wells.  
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However, in LY294002 treated T-conditioned wells, there was still the 
appearance of elongated cells as with the non-treated T-conditioned wells.  
 
5.5 Discussions 
In this study, characterization of primary tumor cells using 
immunostaining and soft agar assay was first carried out. Both W256 cell line (W) 
and tumor explants derived cells (T) displayed similar immunophenotypic 
expression and exhibited anchorage independence that indicated metastatic 
potential. However, size difference in colony formation suggested varying tumor 
subpopulations being propagated.  
Different types of tumor variants would induce differential effects on bone. 
For instance, W256/B variant cells were found to induce osteolytic cortical 
lesions with extension into soft tissues and woven bone was found in the 
subperiosteal area (Badraoui et al 2009). Furthermore, these variant cells were not 
capable of metastasizing to bone after subcutaneous implantation (Rizzoli, & 
Fleisch 1987), unlike the W256/A variant cells. Both observations were found to 
corroborate with the effects of tumor explants cells, suggesting that W256/B 
variant cells might have been derived here.   
In Chapter 4, we demonstrated that there was significant reduction in the 
cell stiffness (and increased hysteresis) of tumor conditioned bone cells associated 
with cytoskeletal changes and possibly variation in bone cell differentiation. It 
was thus postulated that there could also be cytoskeletal mediated changes in 
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mechanosensing of bone cells, which could impact the bone tissue remodeling in 
response to mechanical loading.   
  Mechanosensing of tumor conditioned bone cells to low magnitude, high 
frequency (LMHF) vertical vibration of 0.3g and 30 Hz was investigated in this 
chapter.  It was shown that there was lack of increase of nitric oxide levels in T-
conditioned cells as compared to control bone cells. This implied an inhibition of 
bone cell activation to mechanical loading, given the importance of nitric oxide in 
bone cells biochemical signaling.  Nitric oxide was found to inhibit bone 
resorption effect in-vitro, as it was positively associated with decrease in RANKL 
and increase in OPG protein formation by bone cells (Fan et al 2004).  Thus, the 
lower release of NO by T conditioned cells could imply that there would be 
reduced inhibition of bone resorption, even with mechanical stimuli.  
The significant reduction in the release of NO in response to vibration 
could be positively associated with the changes in f-actin organization and 
mechanical stiffness of the cell. For instance, it was demonstrated that cellular NO 
responses to AFM indentation corresponded to indentations at stiffer locations on 
the osteoblast membrane (McGarry et al 2008).  Thus, it is possible that the 
reduced stiffness of tumor conditioned bone cells associated with altered f-actin 
cytoskeleton, could have contributed to the lower NO response to vibration.  
However, while mechanical properties of both T- and W-conditioned cells 
were significantly less stiff than control cells (as seen in Chapter 4), only T-
conditioned cells were shown here to be significantly inhibited in mechanosensing. 
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This implied that cell mechanical property is not sufficient as an indicator, nor is 
cytoskeletal organization the only factor influencing the mechanosensing process 
of bone cells.    
In Chapter 4, it was found that there were higher levels of TGF-β1 in the 
T-conditioned medium compared to the W-conditioned medium. It is thus 
possible that the presence of growth factors in the conditioned medium could 
serve as negative modulators of the mechanosensing process.  Moreover, it has 
been shown that repeated exposure to low dosage of TGF-β1 could reduce IGF-1 
expression and down regulation of PI3K/Akt pathway, resulting in the inhibition 
of osteoblast differentiation (Ochiai et al, 2011). Since bone cells at different 
differentiation stages have different responses to mechanical signaling (Mikuni-
Takagaki et al, 1996), inhibition of differentiation (even with 3 days exposure to 
tumor released factors) could give rise to differing mechanosensing properties. 
 Bone cells with tumor conditioning were also shown to deposit defective 
bone matrix i.e. amorphous collagen type I formation and reduced mineralization, 
which could affect its adhesion, mechanical and mechanosensing properties. Type 
I collagen has been demonstrated to support osteoblast differentiation and 
maintenance of the bone cell phenotype (Lynch et al 1995).  Hence, defective 
bone matrix deposition arising due to tumor conditioning, could continue to serve 
as a reinforced negative feedback for bone cell differentiation and functionality 
e.g. mechanosensing.  
Therefore, it appeared that tumor released factors e.g. TGF-β might have 
an important role in terms of influencing mechanosensing process. In an earlier 
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study, TGF-β, IGFII and PDGF were shown to mediate their effects on 
cytoskeleton through the PI3K pathway (Mercer & Mastro 2005). Here, 
LY294002, an inhibitor of PI3K was used at a dosage of 1µM (IC50 =1.40µM, 50 
µM completely abolished PI3K activity (Vlahos et al 1994)). It was shown to 
alleviate the inhibition on mechanosensing properties of T-conditioned cells, 
which indicated the involvement of PI3K signaling pathway. It also appeared to 
help maintain cytoskeletal organization of tumor affected cells, which was 
corroborated by an earlier study (Mercer & Mastro 2005).    
Since down regulation of PI3K/Akt pathway inhibited osteoblast 
differentiation (Ochiai et al 2012) and mechanosensing varies with differentiation, 
it was not surprising that nitric oxide levels of LY294002 treated control and W-
conditioned groups decreased, as compared to respective untreated groups. 
However, by alleviating nitric oxide levels of treated T-conditioned groups 
through maintenance of cytoskeleton organization, it did highlight on the 
importance of cytoskeleton in mechanosensing.  Furthermore, it does suggest the 
potential of growth factors such as TGF-β and its downstream molecules as 
pharmacological targets for osteoblast treatment in osteolytic metastasis.  
As an interventional therapy, LMHF vibration at 0.3g and 30Hz, 20mins 
daily intervals did not appear to improve nitric oxide signaling in T conditioned 
bone cells and there was observed desensitization of the W-conditioned bone cells 
to vibration on the consecutive day (2
nd
 day of vibration). There was also a much 
higher standard deviation for control groups on the 2
nd
 day of vibration, which 
could be due to differential responses from heterogeneous bone cells derived from 
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different donors (Neidlinger-Wilke et al 1995). Similarly, a large variability even 
in control cultures was also observed in differences between mechanical 
stimulated and non-stimulated cultures (Kaspar et al 2000).  
ALP activity and bone cell viability was shown to be equivalent to each 
respective non-vibrated group.  Pre-osteoblast and osteoblast cell viability were 
also not affected in another two studies using LMHF vibration (Patel et al 2009, 
Dumas et al 2010). However, ALP activity did not improve significantly, which is 
in contrast to a similar study (Patel et al 2009). Hence, it indicated that there could 
be minimal osteogenic effect on bone cells under current study set-up.  
Given that this is a first study for assessing mechanosensing changes in tumor 
affected bone cells, modification of rest periods between bouts of vibrations and overall 
vibration treatment period would help to determine the efficacy of LMHF vibrations on 
stimulating bone cells affected by tumor. Currently only 24 hour rest periods were used 
between vibrations and redesigning of experimental setup (i.e. use of larger well plates) 
could help to assess the vibration effects over longer duration.   
The osteogenic inducement in bone cells could also be dependent on the 
amplitude of vibration as shown by Rubinacci et al, where 3g rather than 0.6g 
vibration, was shown to improve bone cortex modeling of ovariectomized rats 
(Rubinacci et al 2008). A variety of other factors such as duration of vibration 
(Patel et al 2009, Pre et al 2011), refractory periods between vibration (Sen et al 
2011), frequency (Dumas et al 2010) and direction of vibration (Bacabac et al 
2006) could also contribute to variation in the response of bone cells to vibration.  
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Thus, it is too early to make any conclusions on the efficiency of LMHF 
vibration on stimulating osteogenic response in tumor affected bone cells. As an 
in-vitro vibration study, it would not be readily translatable to effects in-vivo, 
which involved whole body vibration. However, it would help to establish 
protocols which might work in-vivo, given that those that would not work in-vitro 
would have been eliminated.  In addition, it was shown here that there is the 
potential of growth factors such as TGF-β and its downstream molecules as 
pharmacological targets for osteoblast treatment in osteolytic metastasis.   
 
5.6 Conclusions 
Both W256 cell line (W) and tumor explants derived cells (T) displayed 
similar immunophenotypic expression and exhibited anchorage independence that 
indicated metastatic potential. However, size difference in colony formation 
suggested varying tumor subpopulations being propagated, which may explain the 
differences in inhibitive effects on bone cells. Correspondingly, it was 
demonstrated in this study that only T conditioning exerted inhibitive effects on 
nitric oxide release in response to LMHF vibration. It could be due to the higher 
levels of TGF-β1 in T-conditioned medium than that of W-conditioned medium.  
    Here, LY294002, an inhibitor of PI3K signaling pathway through which 
TGF-β, IGFII and PDGF mediate their effects on cytoskeleton, was used at a 
dosage of 1µM. It was shown to alleviate the inhibition on mechanosensing 
properties of T-conditioned cells, possibly through the maintainence of 
cytoskeletal organization in tumor affected cells.  It suggested that growth factors 
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like TGF-β1 could be good pharmocological targets for osteoblast treatment in 



































6.1 Conclusions  
In this thesis, a modified method of immunocompetent model of osteolytic 
metastases was established, with sclerotic healing response (regression phase) and 
a varied osteolytic effect (progression phase).  
At the bone tissue level, a novel characterization of a localized sclerotic 
response from microstructural, densitometric and viscoelastic parameters was 
carried out.  Viscoelastic properties were assessed using nanoindentation and 
dynamic mechanical analysis, with the former technique providing information on 
local mechanical property changes arising due to changes in local cellular (bone 
formation) activity.  Sclerotic response was found to be a healing flare likely in 
response to presence of W256 carcinoma cells. The immune system is postulated 
to be responsible for the evocation of sclerotic bone responses similar to the 
clinical scenario.  Microstructural and densitometric changes showed increased 
bone formation and enhanced trabecular microarchitecture. Significantly reduced 
creep responses in both trabecular and cortical bone were found using 
nanoindentation, whereas elastic properties did not show a significant difference.  
It was concluded that viscoelastic creep property using nanoindentation 
would serve as a more sensitive indicator of localized bone modelling than the 
elastic properties. Since significant positive correlations between elastic 
properties (E) and (H) with viscosity () were also found, it can be postulated that 
sclerotic response (as seen in clinical scenario) could result in lowered damping 




Metastatic cancer cells were found to exert inhibitive effects in vitro on 
osteoblastic cells in terms of proliferation, differentiation and morphology. 
However, there is no prior study on changes of mechanical properties of bone 
cells affected by tumor cells, which could reflect the physiological state of cells 
and affect bone cells in mechanosensing and bone formation activity.  Bone cells 
mechanical property changes due to conditioning from osteolytic tumor explants 
(T) and W256 (W) cells were assessed using atomic force microscopy indentation.   
It was shown in the course of this work that bone cell elastic moduli in W- 
and T-conditioned groups had decreased significantly by 61.0% and 69.6% 
respectively, compared to control. Hysteresis (energy dissipated) was not only 
shown to be negatively correlated to elastic moduli, it was also significantly 
increased in W- and T-conditioned groups.  Changes in bone cell mechanical 
property could be associated with the cytoskeleton changes and possibly inhibited 
bone cell differentiation with tumor conditioning.   
There was also significantly higher inhibition of growth rate (%) and 
higher inhibition of alkaline phosphatase activity (%) at 7 day exposure in T- 
group compared to W-conditioned group. Inhibition of bone nodule formation and 
mineralization was also more apparent in T group than in W group.  It was thus 
demonstrated that there was a stronger sustained inhibitive effect on bone cells 
viability and differentiation by primary tumor cells than the original cell line used. 
This could be attributed to the higher levels of TGF-β1 in T-conditioned medium 




This was also the first study to demonstrate that there was a significant 
changes in mechanical properties of bone cells exposed to tumor conditioned 
medium, which could reflect diseased state of cell and affect its mechanosensing 
properties.  
The mechanosensing changes in primary tumor affected bone cells were 
further examined by assessing nitric oxide (NO) level changes to low magnitude, 
high frequency (LMHF) vibration. By investigating the degree of 
mechanosensitivity of bone cells in vitro, it can also serve to address another need:  
an understanding of how the bone formation process at the cellular level is 
affected by tumor conditioning.  
Characterization of W256 cell line (W) and tumor explants derived cells 
(T) was carried out. Both displayed similar immunophenotypic expression and 
exhibited anchorage independence that indicated metastatic potential. However, 
size difference in colony formation suggested varying tumor subpopulations being 
propagated, which may explain the differences in inhibitive effects on bone cells.  
Correspondingly, it was demonstrated that only T conditioning exerted 
inhibitive effects on nitric oxide release in response to LMHF vibration which 
indicated lowered bone cell activation.  Again, it could be due to the higher levels 
of TGF-β1 in T-conditioned medium than that of W-conditioned medium. 
Here, LY294002, an inhibitor of PI3K signaling pathway through which 
TGF-β, IGFII and PDGF mediate their effects on cytoskeleton, was used at a 
dosage of 1µM. It was shown to alleviate the inhibition on mechanosensing 
properties of T-conditioned cells, possibly through the maintainence of 
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cytoskeletal organization in tumor affected cells.  It suggested that growth factors 
like TGF-β1 could be good pharmocological targets for osteoblast treatment in 
osteolytic metastasis.  
On the other hand, LMHF vibration at 0.3g, 30HZ did not have an 
apparent improvement in stimulating osteogenic response in tumor affected cells. 
Changing the magnitude, frequency, intervals between vibrations and directions 
and type of loading could possibly assist in elucidating the usefulness of LMHF 
vibrations for the stimulation of osteogenesis. As an in-vitro system, it could help 
establish conditions that might work for in-vivo whole body vibrations.  
In conclusion, sclerotic development in this immunocompetent model is 
shown to be reactive bone formation with reduced local creep properties. Nano-
level viscoelastic property was shown to be a sensitive indicator of modelling 
changes in bone.  In addition, the combined inhibition of bone cells viability, 
functionality, mechanical property and mechanosensitivity demonstrated in this 
thesis, could contribute to the defunct bone formation activity as observed in bone 
metastasis. It therefore reinforces the need to expand on osteoblast-targeted 









6.2  Original Contributions 
  There were three main original contributions presented in this thesis. 
Firstly, sclerotic healing response in bone metastasis was characterized and it was 
shown to constitute reactive bone formation, with significantly reduced creep 
responses. Nano-level creep response was indicated to be a sensitive indicator of 
local modelling changes.  
Secondly, through the use of an osteolytic tumor culture derived from in-
vivo model, a significant change in mechanical properties of tumor conditioned 
bone cells was demonstrated. It was positively associated with cytoskeletal 
changes and possibly inhibited bone cell differentiation. There was also a stronger 
sustained inhibitive effect on bone cells viability and differentiation by primary 
tumor cells than the original cell line used. Characterization of primary tumor 
cells indicated metastatic potential and similar phenotypic signature as the 
original W256 cell line, but with higher levels of TGF-β1 released. 
Lastly, mechanosensitivity to LMHF vibration was significantly decreased 
in tumour affected bone cells. By inhibiting PI3K signaling pathway through 
which TGF-β, IGFII and PDGF mediates its effects, inhibition on 
mechanosensing properties of T-conditioned cells was alleviated, possibly 
through the maintainence of cytoskeletal organization.  It suggested the potential 
of growth factors like TGF-β1 as pharmocological targets for osteoblast treatment 
in osteolytic metastasis.  Overall, the combined inhibition of viability, 
functionality and reduced mechanosensitivity could contribute towards the 
defunct bone formation activity as seen in bone metastasis.  
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6.3  Future Work  
Mechanosensing changes of bone cells to fluid-flow could be examined as 
part of future work, since bone cells are well known to respond to fluid flow. Here, 
more attention was paid to low magnitude high frequency (LMHF) vibration since 
it has therapeutic potential to restore bone quality. However, there were no 
significant mechanosensing changes resulting from the vibration intervention 
based on the current set-up. Further optimization of parameters such as frequency, 
loading magnitude, loading direction and timing of treatment intervals could be 
explored further to elucidate its potential for stimulating osteogenic effects in 
tumor affected bone cells.   
Establishing an osteocyte culture would be of interest in terms of studying 
mechanotranduction under the influence of tumor cells. Osteocytes, rather than 
cells of osteoblast lineage are expected to have a bigger role to play in terms of 
mechanotransduction and could provide a stronger basis to determine effects of 
tumor on mechanotransduction and thus bone remodeling.   
On further note, the isolated primary cultured tumor cells have varying 
metastatic potentials (Fidler 2003) and continuous in-vitro culture could have 
expanded one subset of cell population over another.  As such, in-vivo tumor 
induction in SD rat using tumor explants cells could be carried out to demonstrate 
its potency of re-establishing an immunocompetent model of osteolytic 
metastases. Prior to inoculation, the primary tumor cells could be grown in 0.3% 
agarose (top layer) to isolate cells with metastatic potential from the 
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heterogeneous culture (Li et al 1989). The cells could be inoculated intra-
muscular in the muscle adjacent to tibia bone of SD rat (6-8 weeks) to encourage 
bone metastasis (Bassani et al 1990). The choice of intramuscular inoculation was 
also due to the consideration that the primary tumor cells were variant cells 
derived from W256 carcinoma cell line which is originally susceptible to develop 
subcutaneously, intramuscularly or in ascite (Blouin et al 2005). Any primary 
tumor culture expanded from in-vivo implantation could aid in the establishment 
of a metastatic cell line and has been originally used to isolate B16-F10 line from 
B16 melanoma (Fidler 1973).  
One criticism of such in-vivo selection process is that it would result in 
variant population of cells which could survive in the new microenvironment, not 
progeny cells derived from a subset of the heterogeneous parent tumor population 
(Fideler 2003). However, there would be a more reproducible degree of osteolysis 
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